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ABSTRACT
Depression and anxiety are commonly comorbid among patients with chronic medical
conditions. These comorbidities are associated with negative outcomes including poorer quality
of life and worse physical functioning. Evidence that traditional cognitive behavioral therapy
(CBT) is less effective for these populations has led to the development of brief CBT protocols
that incorporate physical health self-management skills and are delivered in primary care. To
continue refining treatment packages, it is important to understand how brief CBT works. The
present study used the transactional model of stress and coping as a framework for investigating
potential mechanisms of action of brief CBT. Veterans with chronic obstructive pulmonary
disease and/or heart failure and elevated symptoms of depression and/or anxiety were
randomized to receive brief CBT (n =180) or enhanced usual care (EUC; n = 122). At 4-month
follow-up, depression and anxiety symptoms were significantly lower in veterans who received
brief CBT, compared to EUC. Multiple mediation analyses revealed that brief CBT was
associated with higher self-efficacy and less avoidant coping at 4-month follow-up, which were
in turn associated with less depression and anxiety symptoms. Illness intrusiveness was also a
significant mediator of the relationship between brief CBT and anxiety symptoms, but not
depression symptoms. In contrast, increases in active coping attributable to brief CBT were not
associated with improvements in depression or anxiety symptoms. These results demonstrate the
utility of the transactional model of stress and coping as a framework for understanding
mechanisms of action of brief CBT in patients with comorbid physical and psychological
conditions.
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INTRODUCTION
There is ample evidence that Cognitive Behavioral Therapy (CBT) is effective for
multiple populations and problems (Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012). These
studies have answered the important question of if CBT is effective and have begun to elucidate
for whom CBT is effective. What is less clear is how or why CBT works. Thus, the National
Institute of Mental Health has called for studies examining potential mechanisms of therapeutic
change (Insel & Gogtay, 2014).
Preliminary evidence from mediation studies suggests that changes in cognitive and
behavioral patterns such as dysfunctional thoughts and active coping account for therapeutic
improvements in depression and anxiety (Gallagher-Thompson, Gray, Dupart, Jimenez &
Thompson, 2008; Kaufman et al., 2005; Smits, Julian, Rosenfield, & Powers, 2012). However,
most studies on the effectiveness and mediators of CBT have been conducted in traditional
mental health settings. It is possible that processes of change vary based on the target population
or therapeutic setting. For example, studies demonstrate that traditional CBT is less effective for
patients with physical and psychological comorbidities (Rutledge, Reis, Linke, Greenberg, &
Mills, 2006). This underscores a need to clarify mechanisms of change for this population.
Of particular interest are patients with chronic obstructive pulmonary disease (COPD)
and heart failure (HF), as there are high rates of comorbid depression and anxiety in these
populations (Konstam, Moser, & De Jong, 2005; Yohannes, Willgoss, Baldwin, & Connolly,
2010), with correspondingly high functional impairment (Burgel et al., 2013; Giardino et al.,
2010). To increase access to mental health care and to better meet the unique needs of these
patients, researchers have developed brief CBT protocols that integrate physical health
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components and that are delivered in the primary care setting (Cully et al., 2017). There is
preliminary evidence that brief CBT is associated with high rates of treatment completion and
improvements in depression and anxiety. However, mechanisms of brief CBT have yet to be
examined and may differ from traditional CBT packages.
Study of potential mechanisms of action should be guided by theory (Kazdin, 2007). The
transactional model of stress and coping is one theoretical model (Lazarus & Folkman, 1984),
the components of which have been helpful for explaining the relationship between chronic
medical conditions and psychological adjustment (Wethington, Glanz, & Schwartz, 2015). There
is evidence that CBT impacts components of the model, including appraisals of illness
intrusiveness (i.e., the degree to which illness interferes with functioning; Edworthy et al., 2003),
self-efficacy appraisals (i.e., beliefs about ability to cope with disease symptoms; O’Leary,
Shoor, Lorig, & Holman, 1988), and coping (i.e., strategies used to address medical illness;
Moorey, Frampton, & Greer, 2003). The potential role of these components in explaining
therapeutic changes in psychological adjustment has yet to be tested.
Therefore, the purpose of this study is to examine potential mechanisms of action of brief
CBT for patients with COPD and/or HF and comorbid depression and/or anxiety, using the
transactional model of stress and coping as a framework. Understanding how brief CBT works in
this population may suggest future avenues for modification of treatment packages.
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COGNITIVE BEHAVIORAL THERAPY: IT WORKS, BUT HOW?
Cognitive behavioral therapy (CBT) is based on the science of behavior (for a history, see
Craske, 2017) and the cognitive model, which posits that psychological disorders are developed
and maintained by dysfunction beliefs and patterns of thoughts (Clark & Beck, 2010). Therefore,
CBT seeks to change unhelpful thoughts and behaviors in order to improve mood and
functioning. As it is most broadly defined, CBT encompasses both cognitive therapy, which
specifically targets thinking patterns and core beliefs, and behavioral interventions, which focus
on skill-building, problem-solving, and increasing enjoyable and meaningful activities. Because
of the strong evidence base for its practice, CBT is considered by many to be the gold standard
for treating depression and anxiety disorders. One review of 16 methodologically rigorous metaanalyses concluded that CBT is an effective treatment, not only for depression and anxiety, but
also for other mental health conditions, such as substance use disorders and posttraumatic stress
disorder (PTSD; Butler, Chapman, Forman, & Beck, 2006). A more recent review of 106 metaanalyses established that CBT is effective for many different disorders and also for individuals
across the lifespan, from children and adolescents to older adults (Hofmann, et al., 2012).
While it is clear that CBT works for many populations and problems, understanding how
it works is a more complex question with important implications. Understanding the mechanisms
of action of CBT may help suggest avenues to improve treatment. For example, treatment
packages may be modified to emphasize interventional elements that affect critical cognitive or
behavioral processes to produce better outcomes. It is timely to examine mechanisms by which
CBT leads to improvements, given that abbreviated protocols are being implemented in primary
care (Cully et al., 2017). Knowledge of critical change processes may suggest avenues for
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tailoring traditional CBT protocols to patients with comorbid medical and mental health
conditions in this setting. The present study focuses on potential mechanisms of action of brief
CBT for patients with comorbid medical and mental health conditions, contributing to a growing
body of literature that examines how CBT works.
Methods of Inquiry
There are two primary ways in which the question of how CBT works has been
examined: component studies and mediation studies. Component studies compare effect sizes of
outcomes when treatment packages include or exclude key intervention components. Two types
of component studies are dismantling studies, which compare the effect of individual
components with a full treatment package, and additive studies, which build interventions by
examining the added effect of an additional treatment component (Papa & Follette, 2015). In
contrast, mediation studies measure potential mechanisms of action and test whether outcomes
are changed through these processes (Kazdin, 2007). Though both methodologies aim to
understand how therapy works, these approaches answer slightly different questions. Component
studies address which therapeutic components are most strongly associated with changes in
outcomes. On the other hand, mediational studies address the processes by which outcomes
change. In summary, component studies answer the question of what treatment components
work, while mediational studies answer the question of how a treatment package works.
Component Studies
Component studies are important for continued development and refinement of CBT
given that their focus is on building effective treatment packages. However, a summary of the
literature provides few clear conclusions regarding necessary treatment components. A metaanalysis of 27 component studies supported the general therapeutic efficacy of CBT, but found
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no significant differences in outcomes for treatment packages with and without hypothesized
critical components (Ahn & Wampold, 2001). These results suggest that, though psychotherapy
is effective, ostensibly important treatment components do not alone account for therapeutic
benefits. A more recent meta-analysis attempted to elucidate the contribution of specific
treatment components by examining dismantling studies and additive studies separately (Bell,
Marcus, & Goodlad, 2013). With regard to dismantling studies, there were no significant
differences in outcomes between full and dismantled treatments. In contrast, additive studies
revealed small but significant effects of added components for specific, targeted outcomes.
Nonetheless, it is difficult to draw broad conclusions about CBT using component studies
because treatment emphases vary widely by target population and setting. More novel
approaches that emphasize the use of treatment modules to customize interventions introduce the
possibility that emphases could even vary on an individual basis. Furthermore, the ability of
component studies to elucidate how certain treatment components work is limited because
underlying processes of change are not examined. The lack of consistent, critical components
coupled with limited generalizability suggest that there is further opportunity to understand how
CBT works. A return to theory to examine the processes by which CBT improves outcomes may
suggest future avenues of investigation to identify critical components of therapy.
Mediation Studies
In contrast to component studies, which look at what elements of treatment work,
mediation studies examine the processes by which therapeutic change in depression and anxiety
occurs. Investigation of potential mediators of CBT for depression and anxiety has broadly been
guided by cognitive theory, which holds that dysfunctional attitudes and patterns of thinking are
responsible for the development and maintenance of depression and anxiety (Clark & Beck,
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2010). Thereby, the cognitive mediation hypothesis posits that CBT improves depression and
anxiety by changing various dysfunctional thinking patterns. Dysfunctional attitudes that have
been shown to significantly mediate therapeutic reductions in depression symptoms include
automatic negative thoughts (Kaufman et al., 2005; Kwon & Oei, 2003), depressive ruminations
(Watkins et al., 2011), hopelessness (Kuyken, 2004), and absolutist, dichotomous thinking
(Teasdale et al., 2001). Two studies have also demonstrated that cognitive changes temporally
precede and predict sudden treatment gains, supporting the cognitive mediation hypothesis (Tang
& DeRubeis, 1999; Tang, DeRubeis, Beberman, & Pham, 2005).
Cognitive mechanisms have been supported with anxiety disorders as well. One that has
received particular attention is threat reappraisal. Individuals with anxiety disorders tend to
misappraise threat by overestimating the likelihood of harm and by magnifying the negative
consequences of anticipated harms (Clark & Beck, 2010). According to the threat reappraisal
mediation hypothesis, CBT leads to reductions in anxiety by modifying inaccurate threat
appraisals (Smits et al., 2012). Threat reappraisal has been established as a statistical mediator of
therapeutic reductions in anxiety in many studies (see Smits et al., 2012 for a review). Overall,
there is strong support that changes in dysfunctional attitudes and threat reappraisal are
mediators of CBT for both depression and anxiety.
As noted previously, mediation studies focus on theoretical mechanisms of change to
explain how CBT works. The robust evidence for mediation models coupled with lack of clear
findings in component studies suggest that a continued emphasis on mediation studies may be
most fruitful for understanding how CBT works, before returning to component studies to
examine which elements of therapy contribute most to therapeutic change. While mediation
studies demonstrate that cognitive processes account for changes in depression and anxiety, to
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definitively establish a causal mechanism, specificity of change processes must be established
(Kazdin, 2007). Returning to theory to illustrate this point, a fundamental assumption underlying
the cognitive and threat reappraisal mediation hypotheses is that these cognitive changes are
specific to cognitive interventions (Whisman, 1993). Establishing specificity of a given mediator
to a particular intervention lends strength to the argument that it is a therapeutic mechanism of
action of that intervention. Consequently, researchers have begun to examine whether cognitive
changes are uniquely related to CBT or due to nonspecific processes found across therapies.
Specificity of Cognitive Mediation
Early studies comparing CBT to pharmacotherapy found that changes in cognition were
comparable across therapies (Imber et al., 1990; Simons, Garfield, & Murphy, 1984). Based on
these findings, researchers concluded that improvements in depression produced cognitive
changes, rather than the reverse. However, these studies measured cognitive change and
depression concurrently. Other studies with more rigorous designs have found that changes in
cognition mediate improvements in depression and anxiety for individuals treated with CBT but
not pharmacotherapy (DeRubeis, Evans, Hollon, Garvey, Grove, & Tuason, 1990; Hofmann et
al., 2007). In particular, Quilty, McBride, and Bagby (2008) measured depression and
dysfunctional attitudes at multiple time points and found that changes in dysfunctional attitudes
preceded and predicted changes in depression for CBT, while the reverse was true for
pharmacotherapy.
In contrast, research comparing CBT to other psychotherapeutic interventions has
produced mixed evidence as to the specificity of cognitive mediation. Studies comparing CBT to
problem-solving therapy (Warmerdam, van Straten, Jongsma, Twisk, & Cuijpers, 2010) and
acceptance and commitment therapy (ACT; Arch, Wolitzky-Taylor, Eifert, & Craske, 2012;
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Forman, Chapman, Herbert, Goetter, Yuen, & Moitra, 2012) have not found evidence that
cognitive mediation is specific to CBT. Conversely, Quilty and colleagues (2008) found that
dysfunctional attitude change mediated reductions in depressive symptoms for patients treated
with CBT but not interpersonal therapy (IPT). These variations in outcome may be explained by
the degree of overlap between CBT and the comparison treatments. While ACT and problemsolving therapy differ in terms of the types of cognitive processes targeted, they may be
subsumed under the umbrella of CBT, using its broadest definition (Hofmann, Sawyer, & Fang,
2010). In comparison, IPT focuses on interpersonal problems and attachment processes and is
therefore more dissimilar (Klerman, Weissman, Rounsaville, & Chevron, 1994). In summary,
there is preliminary evidence that change in cognition serves as a specific mediator of CBT.
Other Potential Mechanisms of Action
Taken together, there is strong evidence that cognitive change is a mechanism of action
CBT, though there is variability in the particular cognitive process targeted across studies.
Although changes in threat reappraisal and various dysfunctional attitudes are well-studied
potential mechanisms of action, there are other potential change processes targeted by CBT. In
particular, behavioral variables that significantly mediate therapeutic change in psychological
functioning include increases in positive and/or meaningful activities and use of active coping
skills (Carvalho & Hopko, 2011; Gallagher-Thompson et al., 2008; Losada, Márquez-González,
& Romero-Moreno, 2010; Strunk, DeRubeis, Chiu, & Alvarez, 2007). Other variables that
significantly mediate therapeutic gains in depression and anxiety include cognitive reactivity and
self-appraisal of problem-solving and coping abilities (Beevers & Miller, 2005; Chen, Jordan, &
Thompson, 2006; Goldin et al., 2012; Segal, Kennedy, Gemar, Hood, Pedersen, & Buis, 2006;
Strunk et al., 2007), and use of adaptive coping skills (Gallagher-Thompson et al., 2008; Strunk
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et al., 2007). It is important to replicate these results in other samples to gain confidence that
these processes may be mechanisms of action of CBT (Kazdin, 2007).
Summary
Overall, there is ample evidence that CBT leads to improvements in mental health
conditions, such as depression and anxiety. The question of how CBT produces therapeutic
change still needs to be answered. Guided by cognitive theory, mediation studies have provided
strong evidence that changes in dysfunctional cognitions partially account for improvements in
depression and anxiety. Continuing to investigate these and other potential mechanisms of action
should provide a more thorough understanding of how CBT works. Next steps in this line of
research include examining models that incorporate multiple potential mediators; doing so may
help elucidate the relative importance of various change mechanisms, suggesting potential
avenues for treatment modification. As suggested by Kazdin (2007), these models should be
driven by a plausible, coherent theory. The transactional model of stress and coping is one
framework which may be used to understand mediators of CBT and which holds particul ar
relevance for patients with comorbid medical and mental health conditions. Future studies also
need to examine whether mediators vary by population and setting. To date, most studies
examining potential mechanisms of CBT have been conducted in outpatient specialty mental
health care settings. It is unclear how mechanisms of action may vary for CBT delivered in other
settings such as primary care and for other populations, such as patients with comorbid medical
conditions.
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TAILORING INTERVENTIONS TO MEET THE UNIQUE NEEDS OF PATIENTS
WITH PHYSICAL AND PSYCHOLOGICAL COMORBIDITIES
Depression and anxiety are frequently comorbid with chronic medical conditions
(Brenes, 2003; Katon, 2003; Kunik et al., 2005; Mikkelsen, Middleboe, Pisinger, & Stage, 2004;
Rutledge et al., 2006). Some medical conditions have particularly high rates of comorbidity. For
example, up to 40% of patients with cardiopulmonary conditions such as COPD and HF meet
criteria for major depression and up to 63% meet criteria for an anxiety disorder (De Jong,
Moser, An, & Chung, 2004; Konstam et al., 2005; Yohannes, Baldwin, & Connolly, 2000;
Yohannes, et al., 2010). These comorbidities are associated with increased healthcare costs
(Maurer et al., 2008), higher healthcare utilization rates (Jiang et al., 2001; Kim et al., 2000),
worse quality of life (Burgel et al., 2013; Giardino et al., 2010; Juenger et al., 2002), and earlier
mortality (Domingo-Salvany et al., 2002; Rumsfeld et al., 1999). However, only 41% of
individuals with a mental health condition receive any psychiatric or psychological intervention
(Wang et al., 2005).
Many patients with comorbid medical and mental health conditions first present to
primary care, often during an annual visit (Wang et al., 2005). However, depression and anxiety
often go unrecognized and undiagnosed due to overlap of symptoms with physical illnesses and
because screening for mental illness is still not standard practice in many primary care settings
(Ballenger et al., 2001; Cafarella, Effing, Usmani, & Frith, 2012). Even when psychological
illness is recognized, patients often will not accept a referral to specialty mental health care
(Kessler et al., 2001; Regier et al., 1993). Lack of follow-up could be due to the patients’
misattributions of all physical and emotional symptoms to comorbid medical conditions
(Dickinson et al., 2005; Keeley et al., 2004; Sarkisian, Lee-Henderson, & Magnione, 2003). Low
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rates of follow-up also may be due to stigma associated with mental healthcare or other barriers
to following up on referrals (Corrigan, 2004; Mojtabai et al., 2011). Regardless of the reason,
this lack of recognition and follow-up care may be especially problematic for patients with
chronic medical conditions that are exacerbated by psychological disorders.
Primary Care Mental Health Integration
While the continuity, comprehensiveness, and coordination of the primary care model are
ideal for patients with mental illnesses such as depression and anxiety disorders, few patients
treated with usual practices in primary care receive adequate mental health care (Young, Klap,
Sherbourn, & Wells, 2001). For example, in a study of 366 patients with anxiety disorders
treated medically in primary care over 3 months, only 40% received appropriate antianxiety
medications and only 25% of these patients received them at a minimally adequate dosage (Stein
et al., 2004). Determinations about the appropriateness of medications and dosage were made a
priori based on evidence-based literature and consensus statements. In a similar series of studies
examining patients with major depression, only 40% received any psychiatric medication (Sturm
et al., 1995; Wells et al., 1994). In addition to inadequate pharmacological intervention, less than
25% of patients who receive mental health care receive any psychotherapy (Wang et al., 2005).
This gap in care is critical, as psychological interventions such as CBT are associated with lower
relapse rates for depression and greater maintenance of treatment gains for patients with anxiety
disorders (Otto, Smits, & Reese, 2005).
In response to this problem of inadequate mental health care, there has been a movement
toward integrating psychological services into primary care settings (Blount, 2003). For example,
the Veterans Healthcare Administration Initiative (Post & Van Stone, 2008) calls for integration
of mental health services in primary care to increase access to and quality of mental health care
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for veterans. While CBT is the gold standard for treating anxiety and depression (Hofmann et al.,
2012), evidence-based treatments have primarily been tested in traditional mental healthcare
settings. The intensity of these treatment packages, typically consisting of 12 or more one-hour,
weekly sessions, does not fit well with the primary care model, which emphasizes brief, episodic
care for specific issues and annual preventive care. Critically, evidence suggests that individuals
with comorbid physical health conditions may benefit from less intensive interventions (Cape,
Whittington, Buszewicz, Wallace, & Underwood, 2010; Nieuwsma et al., 2012). Cully, Paukert,
Falco, and Stanley (2009) also hypothesize that traditional forms of CBT may be less effective
for medically ill patients because they do not address physical health concerns. This may limit
buy-in and engagement, particularly for patients with chronic illnesses like COPD and HF,
which significantly impact physical functioning (Polsky et al., 2005). Indeed, traditional
psychologically based interventions do not have a significant impact on depression and anxiety
in these patients (Brenes, 2003; Rose et al., 2002; Rutledge et al., 2006). Current priorities of
integrating mental health into primary care, coupled with evidence that the gold standard of
treatment does not meet the needs of this population, suggest that future work to tailor
interventions in this area is warranted.
Brief CBT for Comorbid Physical and Psychological Conditions
Recently, researchers have begun to investigate treatment packages delivered in primary
care that incorporate evidence-based treatment elements in an abbreviated format, typically
consisting of four to six 30-minute sessions. Preliminary evidence suggests that abbreviated CBT
is effective for treating depression and anxiety in primary care settings and for patients with
comorbid physical health conditions (Cape et al., 2010; Nieuwsma et al., 2012; Roy-Byrne et al.,
2005; Roy-Byrne et al., 2010; Stanley et al., 2009; Willemse, Smit, Cuijpers, & Tiemens, 2004).
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Preliminary evidence suggests that brief CBT is associated with significant improvements in
depression and anxiety among patients with cardiopulmonary conditions (Freedland et al., 2009,
2015; Kunik et al., 2008). While promising, dropout rates tended to be high. Further, despite the
relationships between mental and physical health, these interventions did not directly address
physical health concerns. This missing physical health component could contribute to drop out,
as many patients view their symptoms as physical, not mental health concerns (Dickinson et al.,
2005).
To address these limitations, Cully and colleagues (2012a) integrated behavioral health
intervention approaches to adapt traditional evidence-based treatments for depression and
anxiety. Focusing on veterans with COPD and HF, they trained mental health providers working
in a primary care setting to deliver a brief CBT protocol that includes physical health selfmanagement skills. This flexible, modular intervention was associated with significant
improvements in depression and anxiety (Cully et al., in 2017). Additionally, patient engagement
and retention was high.
Interestingly, receiving physical health modules earlier in treatment was associated with
greater likelihood of treatment completion (Brandt et al., in preparation). Lack of perceived need
or relevance of mental health treatment is the most prominent reason for drop-out (Kessler et al.,
2001). Thus, it appears that addressing physical health may increase the perceived relevance of
mental health treatment among patients with comorbid medical illness. Taken together, these
findings indicate that incorporating physical health early in treatment is critical for buy-in among
chronic illness populations. In summary, a brief, modular approach to CBT that incorporates
physical health self-management skills shows promise for patients with comorbid medical and
mental health conditions being treated in primary care.
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Mechanisms of Brief CBT
As these protocols develop, an important consideration will be to include the most
effective treatment components. Knowledge of the processes which account for therapeutic
change can help identify which components to include in abbreviated treatment packages.
Although it is increasingly clear that brief CBT works, how it works has not been fully explored.
It is unclear whether brief CBT and traditional CBT share mechanisms of action or if they lead to
change in different ways. There are several reasons that mechanisms of action of brief CBT may
differ from traditional CBT. First, abbreviated interventions may emphasize di fferent cognitive
and behavioral processes than full CBT protocols. Therefore, the relative impact of these
processes on therapeutic outcomes may vary. Second, because the target populations differ,
particular change processes may account for more or less improvement in symptoms. For
example, increases in perceived self-efficacy to address symptoms may be relatively more
important for patients with comorbid medical and mental health conditions, who are managing
multiple illness symptoms. Likewise, while the presence of a medical illness is a real stressor,
inaccurate appraisals of the impact that illness has on functioning can contribute to further
impairment. Therefore, addressing these cognitive distortions may be even more critical in a
medically ill population. Finally, brief CBT protocols which incorporate physical health selfmanagement skills may act through different pathways to improve outcomes. Therefore, it is
important to examine mediators of brief CBT for patients with comorbid medical and mental
health conditions to begin to identify potential mechanisms of action.
Summary
In summary, anxiety and depression are commonly comorbid with chronic medical
conditions such as COPD and HF. These mental health comorbidities have traditionally have
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been under-addressed in the primary care setting, where most patients with medical illness
receive their mental health care. There is mounting evidence that abbreviated CBT delivered in
the primary care setting is an effective intervention for patients with comorbid medical and
mental health conditions. Also, interventions that are adapted to address physical health may be
important for maximizing engagement in this population, particularly for patients with chronic
illnesses, such as COPD and HF, that significantly impact physical functioning. It is critical to
understand what processes lead to therapeutic change in this population, and in what ways these
mediators may differ from traditional CBT protocols. Similar to the investigation of change
mechanisms in traditional CBT, a return to theory to guide these empirical questions is
warranted. The transactional model of stress and coping is one framework which holds
particular relevance for patients with comorbid medical and mental health conditions and which
may be used to understand mediators of brief CBT.
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THE TRANSACTIONAL MODEL OF STRESS AND COPING
The transactional model of stress and coping was first developed by Lazarus (1966) and
later expanded upon by Lazarus and Folkman (1984) as a framework for understanding stressful
events. In particular, Lazarus was interested in the individual differences in stress reactions (i.e.,
why the same event may be stressful to one person and not so to another). The model posits that
humans 1) evaluate potentially stressful events as harmful, threatening, or challenging, 2) assess
their ability to cope with the event, and 3) employ coping strategies. These processes occur in
sequence to impact an individual’s physical and psychological well-being. Over time, the
transactional model of stress and coping has emerged as an important framework for
understanding chronic diseases (Wethington et al., 2015). Pieces of this model have helped to
examine individual differences in psychological adjustment and health behaviors among
chronically ill patients.
Primary Appraisal
Lazarus and Folkman (1984) used the term primary appraisal to describe the evaluation
of whether a stressor is relevant and whether it poses a threat, “harm -loss,” or challenge. If a
situation is appraised as threatening, the individual views potential for future harm. For example,
an individual newly diagnosed with congestive heart failure may perceive this disease as
threatening because he anticipates having a heart attack. A harm-loss appraisal occurs when it is
perceived that a harm or loss has already transpired. For instance, a patient with chronic pain
may view this condition as a loss of independence and functional ability. In contrast to threat and
harm-loss appraisals, challenge appraisals are a more positive perspective on potential stressors.
To illustrate, a patient who is told that she is pre-diabetic may view this as an opportunity to
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improve her health and prevent the illness from progressing. Primary appraisal may also involve
perceptions about the relevance and importance of disease symptoms. In particular, individuals
may differ in their evaluations of how intrusive symptoms are and how much they interfere with
functioning. These appraisals of symptoms and perceptions of vulnerability to disease partially
account for the psychological adjustment of chronically ill individuals (Leventhal & Patrick Miller, 1993); they also appear to be linked to physical health outcomes (Bigatti, Steiner, &
Miller, 2012).
The association between primary appraisals and outcomes such as psychosocial
adjustment and health status has been examined in several medically ill populations. In patients
with cancer, primary appraisals of threat and harm-loss are associated with poor psychological
adjustment (Bigatti et al., 2012; Jenkins & Pargament, 1988) and worse quality of life (Song,
Rini, Ellis, & Northouse, 2016). Similarly, primary appraisals of threat and loss due to cardiac
disability are significant predictors of depression and anxiety 3-4 years after hospitalization for
myocardial infarction (Waltz, Badura, Pfaff & Schott, 1988).
With regard to perceptions of symptom severity and illness intrusiveness, there is a
consistently high correlation between appraised severity of neuropsychological symptoms and
emotional dysfunction among patients with traumatic brain injuries (TBIs; Godfrey, Partridge,
Knight, & Bishara, 1991; Fordyce & Roueche, 1986). Greater perception of illness intrusiveness
is also predictive of psychological distress among patients with renal failure (Devins, 19 94) and
multiple sclerosis (Mullins, Cote, Fuemmeler, Jean, Beatty, & Paul, 2001). In terms of physical
health outcomes, cardiac patients with poorer self-perceptions of health and higher illness
intrusiveness are at higher risk of major adverse cardiac and cerebrovascular events (Cserép et
al., 2010). Likewise, belief that pain unavoidably interferes with normal functioning is associated

17

with physical disability among patients with chronic pain (Riley, Ahern & Follick, 1988; Slater,
Hall, Atkinson, & Garfin, 1991). Overall, negative primary appraisals of disease symptoms are
associated with poorer psychological and physical functioning among patients with chronic
medical conditions.
Secondary Appraisal
According to Lazarus and Folkman (1984), secondary appraisal involves evaluation of
whether an individual has the resources necessary to cope with a stressor and the perceived
ability to deploy these resources. One type of secondary appraisal involves an individual’s belief
in their ability to produce desired changes. This self-efficacy belief varies across contexts, but
has also been examined in a global manner. In a review of studies on general beliefs of efficacy,
Jerusalem and Mittag (1995) concluded that, in the face of a stressor, low self-efficacy is
associated with strong negative emotional reactions and somatic complaints. High rates of
depression and anxiety found in patients with chronic medical conditions suggest that selfefficacy may play an important role for this population. Therefore, self-efficacy to engage in
health behaviors and manage disease symptoms has been a particularly salient construct for
capturing the secondary appraisal process. Cohen and Rodriguez (1995) suggest that distorted
thinking patterns linked to physical illness may predict decreased self-efficacy, which is in turn
associated with affective disturbance (Beck, Rush, Shaw & Emery, 1979). For example, patients
with COPD who have low self-efficacy may lack confidence in their ability to avoid breathing
difficulty while engaging in activities. Consequent inactivity and attention to somatic symptoms
may then lead to depression and anxiety. Thus, appraisal of capacity to cope with symptoms has
potentially important implications for psychological and physical health outcomes in pati ents
with chronic illness. Secondary appraisal of ability to manage disease symptoms has been
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examined as a predictor of psychological adjustment and physical functioning in individuals with
various medical conditions. In terms of physical functioning, patients with low self-efficacy are
less able to tolerate pain (Litt, 1988; Manning & Wright, 1983) and have worse overall physical
functioning (Arnold et al., 2005), whereas higher self-efficacy is associated with implementation
of health behaviors (Joekes, Van Elderen, & Schreurs, 2007) and enhanced recovery of
cardiovascular functioning (Taylor, Bandura, Ewart, Miller, & DeBusk, 1985).
Self-efficacy is also positively related to psychological adjustment in individuals with
chronic illness. A review of studies examining self-efficacy in patients with chronic pain
demonstrated that stronger beliefs in ability to perform activities of daily living and to manage
pain and other symptoms are associated with better psychological adjustment (Jensen, Turner,
Romano, & Karoly, 1991). Likewise, higher self-efficacy is positively related to psychological
adjustment and quality of life for individuals with cardiac disease (Joekes et al., 2007; van
Jaarsveld, Ranchor, Sanderman, Ormel, & Kempen, 2005). In contrast, lower self-efficacy of
symptom management predicts higher levels of depression and anxiety among patients with
COPD (McCathie, Spence & Tate, 2002). In sum, secondary appraisal of self-efficacy is an
important predictor of physical and psychological functioning in patients with chronic illness.
Coping
Coping strategies are the tactics that individuals employ to address a perceived stressor
(Lazarus & Folkman, 1984). There are many coping strategies that researchers have categorized
in various ways over time. One conceptualization categorizes coping strategies as emotionfocused and problem-focused (Lazarus & Folkman, 1984). Problem-focused coping strategies
consist of attempts to directly confront a stressor while emotion-focused coping strategies focus
on moderating emotional reactions to a stressor (Folkman & Lazarus, 1980; Lazarus & Folkman,
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1984). Another prevailing approach to examining coping strategies categorizes these same
strategies as approach/active or avoidant. Active coping is the process of addressing a stressor to
reduce its intensity or potentially harmful effects; strategies employed may be cognitive,
behavioral, or emotionally-focused (Roth & Cohen, 1986). Avoidant coping involves attempts to
evade or deflect a stressor by means such as ignoring, discounting, or psychological distancing
(Roth & Cohen, 1986).
To parse the literature on coping, this review will focus on the categorization of coping
strategies as active and avoidant, for the following reasons. First, literature on the utility of
emotion-focused coping is mixed, with some strategies yielding positive outcomes and others
producing negative results (Bombardier, D’Amico, & Jordan, 1990; Worthington & Scherer,
2004). This is likely a reflection that the umbrella of emotion-focused coping includes coping
strategies that fall within both avoidant and active categories. Second, the helpfulness of
problem-focused and emotion-focused coping is thought to be dependent on the context and
characteristics of the stressor, such as controllability (Forsythe & Compas, 1987). In contrast to
the contextual conceptualization of problem- and emotion-focused coping, avoidant coping has
been fairly consistently conceptualized as maladaptive, with active coping serving as more
adaptive responses to stressors (Holahan & Moos, 1985; Roth & Cohen, 1986). Therefore, to
provide parsimony and enhance clarity, all studies will be interpreted in terms of active and
avoidant coping.
According to Sachs (1991), “failure to cope well with stress can enhance illness” whereas
“adequate coping reflects psychological strength that promotes health” (p. 61). Physical illnesses
have come to be recognized as stressors that place demands on a person and require the
deployment of coping strategies (Endler, Parker, & Summerfeldt, 1993; Moos & Tsu, 1977). The

20

more that changes in health behavior require a departure from routine, the more likely the illness
will be perceived as a significant stressor, resulting in emotional distress (Mandler, 1984).
Additionally, use of maladaptive coping strategies in response to physical illness, such as
increased alcohol consumption, illicit substance use, and behavioral disengagement, can
intensify negative emotional responses (Cohen & Rodriguez, 1995). This resultant emotional
distress may then enhance illness. Therefore, it is important to understand how coping strategies
may impact the physical and psychological health of individuals living with medical illness, as
adaptive coping strategies may promote good health.
Reviews of the literature have taken an integrative approach in their examination of
avoidant and active coping in order to understand how each uniquely contributes to health and
dysfunction. In meta-analyses of individuals with HIV (Moskowitz, Hult, Bussolari, & Acree,
2009) and diabetes (Duangdao & Roesch, 2008), avoidant coping strategies were associated with
poorer outcomes across domains for individuals with HIV and with poorer psychological
adjustment for patients with diabetes. Active coping strategies were positively associated with
psychological health, physical health, and health behaviors in both populations. A review of the
literature on coping and adjustment to chronic pain reveals associations between avoidant coping
strategies and negative psychological and physical health (Jensen et al., 1991). In contrast, active
coping strategies were associated with positive outcomes in these domains.
In addition to broad associations, research in specific populations supports these
relationships. For example, avoidant coping is associated with higher levels of depression and
anxiety in patients with chronic medical conditions such as COPD (McCathie et al., 2002) and
breast cancer (Bigatti et al., 2012), even after controlling for physician-rated disease severity
(Bombardier et al., 1990). In contrast, cognitive reappraisal, an active coping strategy, is
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associated with better emotional adjustment following TBI (Moore, Stambrook, & Peters, 1989).
Additionally, cancer survivors who implement active coping strategies are more likely to engage
in positive health behavioral changes than those who use avoidant coping approaches (Parelkar,
Thompson, Kaw, Miner, & Steinl, 2013). In summary, coping strategies are significantly related
to adjustment in the face of chronic illness as a stressor. In particular, avoidant coping is
negatively associated with outcomes, while active coping is predictive of positive outcomes.
Impact of Psychological Intervention on Appraisals and Coping
Consistent with the transactional model of stress and coping, appraisals and coping are
broadly predictive of adjustment to chronic illness. Based on these associations, researchers have
recommended that psychological interventions be implemented to target appraisals and coping in
an effort to improve psychological and physical health outcomes (Godfrey et al., 1996).
However, few studies have explicitly considered whether interventions lead to changes in
appraisals and coping. One study of brief supportive-expressive group psychotherapy for women
with lupus found significant reductions in perceived illness intrusiveness (Edworthy et al., 2003).
Similarly, self-efficacy increased among patients with rheumatoid arthritis (RA) after
participation in a self-management program (Holman & Lorig, 1992). In terms of CBT, studies
have demonstrated improvements in self-efficacy for patients with COPD and RA (Kaplan,
Atkins, & Reinsch, 1984; O’Leary et al., 1988). Many studies that examine interventions to
improve coping focus on changes in disease-specific health behaviors, rather than broader
patterns of avoidant and active coping. For example, CBT leads to decreases in substance use
and improvements with compliance to medical regimens (McHugh, Hearon, & Otto, 2010;
Safren et al., 2009), which may be categorized as avoidant and active coping strategies,
respectively (Cooper, Frone, Russell, & Mudar, 1995; Weaver et al., 2005). In a notable
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departure from this focus on specific behaviors in the coping literature, a study conducted with
patients who participated in cognitive therapy for cancer found general increases in active coping
skills (Moorey et al., 2003). Although this literature is in its infancy, there is preliminary support
that psychological interventions impact components of the transactional model.
Summary
The transactional model of stress and coping provides a strong theoretical framework for
understanding the relationship between physical illness and psychological health, where illness is
conceptualized as a stressor. This model is particularly helpful for explaining the high rates of
comorbidity between chronic medical conditions, such as COPD and HF, and psychological
disorders, including depression and anxiety. There is a burgeoning body of literature supporting
the role of appraisals and coping in psychological adjustment to medical illness. Thus,
researchers have begun to investigate psychological interventions which may change appraisals
and coping, in an effort to improve psychological and physical health outcomes. There is
preliminary evidence that psychological interventions can positively impact appraisals and
coping strategies. Coupled with the literature demonstrating that CBT improves depression and
anxiety among individuals with chronic illness, there is some suggestion that the processes of
appraisal and coping posited by the transactional model may be involved in therapeutic change in
this population. Notably, this has yet to be tested.
Overall, strong theory and clear linkages among posited constructs suggest that appraisal
and coping may serve as mediators of CBT for depression and anxiety in patients with chronic
illness. However, there are several gaps in the literature that must be addressed before this
conclusion can be definitively drawn. In particular, there is a dearth of studies that examine all
components of the transactional model to understand unique linkages between components and
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outcomes. It is important to examine the complete model within a single sample to begin to
understand the relationships among each of these processes and their relative impact on
outcomes. Additionally, the transactional model of stress and coping has been more thoroughly
examined in some populations (e.g., chronic pain) than others. The full transactional model
should be examined in other medical illnesses, such as COPD and HF, in which highly comorbid
depression and anxiety exacerbate illness and lead to greater functional impairment. Finally,
there is encouraging literature that intervention may impact components of the transactional
model of stress and coping. However, there are no studies to date that test whether therapeutic
changes in psychological outcomes are accounted for by changes in primary appraisals,
secondary appraisals and coping. The present study aims to address these gaps in the literature.
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THE PRESENT STUDY
The purpose of this study was to examine potential mechanisms of action of brief CBT
for patients with COPD and/or HF and comorbid mental health concerns. To effectively establish
these causal mechanisms, mediation analyses must go beyond demonstration of a strong
relationship between the intervention, the proposed mediator of change, and the intervention
outcome. According to Kazdin (2007), hypothesized mechanisms of change should be plausible
and coherent, meaning they are reasonably supported by other research and driven by theory.
Therefore, the present study used the transactional model of stress and coping as a framework for
understanding the processes by which brief CBT leads to improvements in depression and
anxiety. It was posited that several theoretical constructs might account for therapeutic change.
First, brief CBT might impact primary appraisals, decreasing the perceived threat of the stressor
(i.e., COPD and/or HF). Second, brief CBT might impact secondary appraisals, increasing the
perceived ability to address the stressor. Third, brief CBT might impact strategies used to cope
with the stressor.
In the present study, primary appraisal was operationalized as illness intrusiveness, or the
degree to which COPD and/or HF symptoms are perceived to interfere with functioning.
Secondary appraisal was operationalized as self-efficacy for managing chronic illness, or the
perceived ability to cope with COPD and/or HF symptoms and prevent them from impairing
functioning. In terms of coping, both avoidant and active coping strategies were examined in this
study, since each type of coping may uniquely predict dysfunction and health.
Participants in the current study were randomly assigned to receive brief CBT or
enhanced usual care (EUC). Brief CBT was flexible, allowing the patient and provider to
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collaboratively choose content from several optional treatment modules, and consisted of four to
six sessions. EUC consisted of documentation of significant symptoms of depression and anxiety
in the medical record. Previous analyses conducted with this sample indicated that participants
who received brief CBT experienced significant improvements in depression and anxiety
symptoms compared to participants who received EUC (Cully et al., 2017). To better understand
how these changes occurred, the present study examined how post-intervention measures of
illness intrusiveness, self-efficacy, and coping might account for post-intervention differences in
depression and anxiety symptoms across treatment conditions. Specifically, mediators measured
at 4-month follow-up (immediately post-treatment) were included as predictors of depression
and anxiety symptoms at 4-month follow-up.
Using multiple mediation analyses with depression and anxiety as the outcome variables
and treatment condition (brief CBT vs EUC) as the predictor variable, the following hypotheses
were tested:
1) illness intrusiveness mediates the relationship between treatment condition and
depression and/or anxiety, such that brief CBT is associated with lower perceived illness
intrusiveness, which is in turn associated with lower symptoms of depression and
anxiety;
2) self-efficacy mediates the relationship between treatment condition and depression and/or
anxiety, such that brief CBT is associated with higher perceived self-efficacy, which is in
turn associated with lower symptoms of depression and anxiety;
3) avoidant coping mediates the relationship between treatment condition and depression
and/or anxiety, such that brief CBT is associated with less avoidant coping, which is in
turn associated with lower symptoms of depression and anxiety;
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4) active coping mediates the relationship between treatment condition and depression
and/or anxiety, such that brief CBT is associated with more active coping, which is in
turn associated with lower symptoms of depression and anxiety.
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METHODS
The current study used data from a randomized controlled trial which compared enhanced
usual care (EUC) to brief CBT in the context of primary care for veterans with comorbid
cardiopulmonary conditions and significant symptoms of depression and/or anxiety (Cully et al.,
2017). The study was approved by local Veterans Affairs Medical Center Research and
Development Committees as well as institutional review boards at Baylor College of Medicine
and the University of Oklahoma Health Science Center. Recruitment lasted from February 2011
to November 2013. Participants provided informed consent and were followed for one year.
Participants in both treatment conditions were compensated up to $110 for study assessments
($20 for baseline, and $30 each for 4-, 8-, and 12-month follow-ups).
Participants
Recruitment. Medical records at the Houston and Oklahoma City Veterans Affairs
Medical Centers were reviewed by research assistants to identify veterans with an Int ernational
Classification of Disease (ICD-10) diagnosis of COPD and/or HF who had received care in the
past year. Opt-out letters were mailed to eligible participants and study staff contacted
individuals who did not opt out up to three times to assess interest in participating in the study.
Interested participants completed a telephone screening process.
Inclusion/Exclusion Criteria. To be included in the parent trial, veterans had to report
mild or greater functional impairment associated with COPD, as measured by the Medical
Research Council (MRC; Fletcher, 1960; Bestall et al., 1999) dyspnea scale (score ≥ 3), or HF,
as measured by the New York Heart Association (NHYA; Bennett, Riegel, Bittner, & Nichols,
2002) classification (class 2 or greater). Severity ratings were reviewed by consultant
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cardiologists and pulmonologists. Participants were also required to report at least moderate
symptoms of depression (PHQ-9 score ≥ 10) and/or anxiety (BAI score ≥ 16) at baseline.
Though participants were required to report significantly elevated symptoms of depression and
anxiety, they were not required to meet full DSM-IV diagnostic criteria for a depression or
anxiety disorder. Veterans who screened positive on the Mini-International Neuropsychiatric
Interview (MINI; Sheehan et al., 1998) for cognitive impairment, current substance use,
psychotic, or bipolar disorders were excluded. Participants with suicidal ideation without intent
or plan were included, while those with active intent or plan to commit suicide were excluded. A
medical records review was completed prior to randomization to ensure that participants were
not actively engaged in psychotherapy and to confirm eligibility to receive primary care mental
health services.
Randomization. Participants were randomized at a central location by the overall study
coordinator using sealed envelopes. For each group of participants (COPD, HF, and both
conditions), random number lists with blocks of 10 were used to allocate 60% of participants to
brief CBT and 40% to EUC. This unequal randomization procedure was used to increase the
number of participants receiving the clinical intervention and to increase the power of the trial.
Sample Selection and Attrition. Medical records were reviewed for 8835 eligible
participants. Of these veterans, 1387 were screened and 432 went on to receive baseline
assessments (Figure 1). Several veterans were excluded prior to randomization due to
experiencing a crisis/emergency (n = 3), moving to another VA (n = 1), or declining to
participate (n = 2). After exclusions for subthreshold BAI and PHQ-9 (n = 122), the total sample
included 302 participants, 180 randomized to brief CBT and 122 to EUC.
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For the purposes of this study, attrition was defined as being lost to follow-up. At 4months follow-up, the overall attrition rate was 22.85% (n = 69), with slightly higher attrition in
the brief CBT condition (n = 48; 26.67%) than the EUC condition (n = 21; 17.21%). See Figure
1 for details of attrition at each time point and reasons for dropout.
Treatment Conditions
Enhanced Usual Care. EUC consisted of an assessment of anxiety and depression (e.g.,
MINI and baseline BAI and PHQ-9) with documentation in patients’ medical records
recommending that symptoms be addressed according to standard clinical practices. If
participants reported suicidal ideation, their primary care provider was notified.
Brief Cognitive Behavioral Therapy. The clinical intervention was designed to include
six weekly or bi-weekly sessions of brief CBT delivered over a 4-month period. Sessions lasted
30 to 45 minutes and were delivered in person or via phone. Additionally, participants received
two brief (10- to 15-minute) “booster” sessions delivered via phone. All sessions included core
elements of CBT such as agenda setting, homework assignments, goal setting, and action
planning. The first two introductory sessions were required for all participants and were designed
to set initial treatment goals. Thereafter, participants and providers collaboratively chose content
from a range of elective skill modules based on participant need. Participants were allowed to
receive the same skill modules more than once, as needed. The sixth session was a “wrap up”
session. Content for the required sessions and elective skill modules are described below.
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Database Extraction
(n = 20800)

Chart Reviews Completed
(n = 14702)

•

Chart review not completed
(n = 6098)

•
•

•
•

Deceased/End of life care (n = 1134)
No diagnosis of a heart or lung condition in chart
(n = 914)
Incomplete contact information (n = 18)
Living (n = 1176) or receiving primary care outside of
catchment areas (n = 582)
Documentation of substance abuse/dependence:
(n = 166), alcohol abuse/dependence: (n = 184),
Bipolar disorder: (n = 204), Schizophrenia disorder:
(n = 241), Dementia (n = 386)
Receiving specialty mental health care (n = 1862)
Total excluded based on chart review (n = 5867)

•

Letters not mailed (n = 74)

•
•
•

Eligible from Chart Review
(n = 8835)

Letters Sent
(n = 8761)

Screening Appointment Completed
(n = 1387)



Eligible for Baseline Assessments
(n = 651)

Completion of Baseline Assessments
(n = 432)

•
•
•
•
•
•
•
•
•

Unable to contact (n = 2253)
Refusal to participate (n = 4896)
PCP outside service area (n = 32)
Deceased (n = 148)
Dementia (n = 23)
Ineligible for services, CHAMPVA (n = 4)
Other health issues that prevent participation (n = 9)
Currently receiving MH treatment (n = 9)
Total excluded after letters sent (n = 7374)

•
•
•
•
•
•
•
•

NYHA/MRC requirements not met (n = 325)
Absence of anxiety or depression (n = 217)
Ineligible for comorbid mental health condition (e.g.,
bipolar, psychosis, substance abuse (n = 140)
Cognitive Screen not met (n = 24)
In MH treatment, ineligible (n = 25)
No longer receiving treatment from VA (n = 4)
Visually impaired (n = 1)
Total excluded at/after screen (n = 736)

•
•
•
•

Unable to contact after 3 attempts (n = 85)
Refusal to participate (n = 128)
Not scheduled due to Recruitment ended (n = 6)
Total excluded before baseline assessment (n = 219)

Figure 1. CONSORT Flow Chart demonstrating flow of participants through study from recruitment to follow-up.
PCP = primary care provider; CHAMPVA = Civilian Health and Medical Program of the Department of Veterans
Affairs; MH = mental health; NYHA = New York Heart Association Classification; MRC = Medical Research
Council Dyspnea Scale; BAI = Beck Anxiety Inventory; PHQ-9 = Patient Health Questionnaire.
(Continued)
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•
•
•
•

Randomized Participants
(n = 302)




•
•

Usual Care
(n = 122)
75 = Chronic Lung Condition;
31 = Heart Failure; 16 = Both

BAI and PHQ-9 requirement not met (n = 122)
Crisis Emergency (n = 3)
Participant not able to validly complete measures (n = 2)
Receiving treatment from another VA (n = 1)
Dropped from program before randomized (n = 2)
Total excluded before randomization (n = 130)




Brief CBT
(n = 180)
112 = Chronic Lung Condition;
44 = Heart Failure; 24 = Both

Reasons Lost to
follow up (n = 48)

Reasons Lost to
follow up (n = 21)






Unable to contact/
unknown (n = 13)
Deceased (n = 2)
Health/Family/
Work (n = 5)
Participant research
burden (n = 1)



4 month
Assessment
completed
(n = 132)

4 month
Assessment
completed
(n = 101)

Reasons Lost to
follow up (n = 22)






Unable to contact/
unknown (n = 10)
Deceased (n = 4)
Health/Family/
Work (n = 6)
Participant research
burden (n = 2)





Unable to contact
/unknown (n = 24)
Deceased (n = 2)
Health/Family/
Work (n = 15)
Participant
research burden
(n = 7)

Reasons Lost to
follow up (n = 52)


8 month
Assessment
completed
(n = 100)

8 month
Assessment
completed
(n = 128)





Unable to contact/
unknown (n = 26)
Deceased (n = 5)
Health/Family/
Work (n = 13)
Participant
research burden
(n = 8)

Reasons Lost to
follow up (n = 23)






Unable to contact/
unknown (n = 11)
Deceased (n = 4)
Health/Family/
Work (n = 5)
Participant
research burden
(n = 3)

Reasons Lost to
follow up (n = 55)


12 month
Assessment
completed
(n = 99)

12 month
Assessment
completed
(n = 125)





Unable to contact/
unknown (n = 31)
Deceased (n = 6)
Health/Family/
Work (n = 10)
Participant
research burden
(n = 8)

Figure 1. CONSORT Flow Chart demonstrating flow of participants throu gh study from recruitment to
follow-up.
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Session 1: Chronic cardiopulmonary disease and stress. This required first session
provided psychoeducation about the treatment program, chronic cardiopulmonary disease, stress,
and mental health. The focus of this session was on engaging patients in care and on providing
empathy as well as structure and support to facilitate self-care. For homework, participants
identified their most pressing emotional and physical concerns and past coping techniques.
Session 2: Understanding personal impact and increasing control. In this required
second session, participants explored the impact of their illness on functioning, discussed prior
coping techniques, established treatment goals, and created an “action plan” to achieve these
goals. Providers delivered psychoeducation about the importance of goal-setting and taught
effective goal-setting techniques. Directed by the patient’s identified goals, providers and
participants collaboratively chose elective skill modules for sessions three through five.
Sessions three through five could consist of any of the following modules, in any order.
Participants created an action plan to implement the new skills learned at the end of each session.
Module A: Taking control of your physical health. The emphasis of this module was on
how healthy behaviors (e.g., exercise, healthy diet) can help to manage chronic illness.
Participants could elect to focus on various skills that addressed nutrition, appropriate exercise,
communicating with their medical provider, managing medications, and coping with flare-ups.
Module B: Using thoughts to improve wellness. The emphasis of this module was on
modifying negative thoughts by identifying and implementing coping statements. Providers
helped participants to identify negative thoughts and unhelpful thinking patterns. Participants
then practiced modifying negative thoughts to be more realistic and practiced generating helpful
self-statements.
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Module C: Increasing pleasant activities. The emphasis of this module was behavioral
activation. Psychoeducation about the link between activities and mood was provided, enjoyable
activities were discussed, barriers to engaging in these activities were identified, and providers
suggested strategies to address these barriers. Participants were provided with a log to record
their daily activities and subsequent mood.
Module D: Learning how to relax. The emphasis of this module was relaxation
techniques. Providers delivered psychoeducation about the role of relaxation in improving
physical and mental health and guided participants in two relaxation exercises: deep breathing
and guided imagery.
Wrap-up session. Providers reviewed the skills participants had learned and reviewed
their treatment progress. Continued use of skills in daily life was discussed and therapy was
closed.
Booster sessions. The aim of booster sessions was to reinforce skills learned during
treatment. Booster sessions were offered 1- and 2-months after treatment and were delivered via
phone.
Brief CBT Providers. Mental health providers who were affiliated with the primary care
clinic and who provided psychotherapy as part of their scope of practice were recruited to deliver
the brief CBT intervention. Providers (n = 19) were existing clinical staff or advanced trainees
and included psychologists (n = 6), social workers (n = 2), physician assistants (n = 2),
psychology fellows (n = 6), and psychology interns (n = 3). To provide basic knowledge of the
intervention, therapists received a clinician manual and patient workbook. Therapists also
participated in a comprehensive, online training program (www.vaprojectaccess.org) which
included narrated slides and audio vignettes to illustrate the application of key intervention
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components. The provider manual and patient workbook are available through the VA South
Central Mental Illness Research, Education, and Clinical Center website (at
http://www.mirecc.va.gov/visn16/docs/ACCESS_Clinician_Manual.pdf and
http://www.mirecc.va.gov/visn16/docs/ACCESS_Patient_Workbook.pdf, respectively). External
facilitators with expertise in brief CBT communicated with providers regularly throughout the
trial to convey information about implementation and address questions or concerns about the
intervention. Primary care mental health integration (PCMHI) clinic directors were engaged to
internally facilitate the adoption of brief CBT by providing resources and streamlining clinical
processes.
Fidelity
To assess intervention fidelity, all sessions were audio recorded and reviewed by two
licensed clinical psychologists who were not providing the intervention. An established scale
(Cully et al., 2012b) ranging from 1 to 8 (excellent) was used to rate intervention adherence and
provider competence. Recordings were also used to deliver feedback to providers. Each
provider’s first therapy patient was reviewed; feedback was provided after the second session
and at the end of treatment. Thereafter, a random selection of sessions was audited and feedback
was provided to each provider for at least two sessions every four months. For each provider,
raters audited an average of 7.2 sessions. Adherence (M = 7.2) and competence (M = 6.2) ratings
generally fell in the “good” to “very good” range for all providers.
Measures
Following initial screening, assessments were conducted at baseline and 4-, 8-, and 12month follow-up periods. Baseline assessment occurred within a month of initial screenings. For
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a complete index of measures collected in the parent trial and for the assessment schedule, see
Table 1.
Table 1
Assessment Schedule
Measure

Screen

Chart Review (confirmation of COPD/ HF)

X

PRIME – MD

X

MINI

X

Cognitive Screen

X

Demographic Information

Baseline

4wks post
baseline

4 mo
F/U
(post tx)

8
mo
F/ U

12 mo
F/U

X

NYHA

X

X

X

X

MRC

X

X

X

X

MINI – depression and anxiety modules

X

PHQ-9

X

X

X

X

GDS

X

X

X

X

BAI

X

X

X

X

PSWQ-8

X

X

X

X

CRQ

X

X

X

X

KCCQ

X

X

X

X

SF-12

X

X

X

X

Spirituality Measures – BMMRS

X

X

X

X

Illness Intrusiveness Rating Scale (HF and

X

X

X

X

Locus of Control

X

X

X

X

Self-Efficacy

X

X

X

X

COPE

X

X

X

X

X

COPD)

(continued)
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Measure

Screen

Baseline

Chart Review (medications)

X

Health Service Use

X

4wks post
baseline

4 mo
F/U
(post tx)
X

8
mo
F/ U
X

12 mo
F/U
X
X

Exit Interview w/CSQ *

X

Working Alliance Inventory (Patient Form)*

X

Working Alliance Inventory (Therapist Form)*

X

Therapist Rating of Patient Engagement/

X

Adherence*
Treatment Expectancy (Expectancy Rating

X

Scale)*
Note. X indicates time-points when measures were administered. wks = weeks; mo = month; F/U = Follow-up; ; tx =
treatment; COPD = Chronic Obstructive Pulmonary Disease; HF = Congestive Heart Failure; PRIME – MD =
Primary Care Evaluation of Mental Disorders; MINI = MINI International Neuropsychiatric Interview; NYHA =
New York Heart Association Classification; MRC = Medical Research Council Dyspnea Scale; PHQ-9 = Patient
Health Questionnaire; GDS = Geriatric Depression Scale; BAI = Beck Anxiety Inventory; PSWQ-8 = Penn State
Worry Questionnaire; CRQ = Chronic Respiratory Disease Questionnaire; KCCQ = Kansas City Cardiomyopathy
Questionnaire; SF-12 = 12-Item Short Form Health Survey; BMMRS = Brief Multidimensional Measure of
Religiousness/Spirituality; COPD = Chronic Obstructive Pulmonary Disease; HF = Congestive Heart Failure; CSQ
= Client Satisfaction Questionnaire. *Denotes measures administered by research assistants to keep independent
evaluators blind to group assignment.

Outcome Measures. The present study examined outcome measures assessed at the 4month follow-up period. As groups did not differ significantly at baseline in terms of depression
or anxiety, baseline scores for these outcomes were not included in analyses.
Depression symptoms were assessed using the Patient Health Questionnaire (PHQ-9), a
nine-item self-report measure commonly used in healthcare settings (Kroenke & Spitzer, 2002).
Although scores may be inflated in populations of older adults with medical conditions due to
overlap in symptoms (Spangenberg, Forkmann, Brähler, & Glaesmer, 2011), the PHQ-9 is one of
the most widely used screening tools for depression in primary care (Arroll et al., 2010). On the
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PHQ-9, patients rate how often they were bothered by symptoms over the past two weeks on a
four-point scale ranging from “Not at all” (0) to “Nearly every day” (3). Total scores range from
0 to 27, with scores ≥10 suggesting the presence of clinically significant symptoms of
depression. Scores from the PHQ-9 have demonstrated good psychometric properties (Löwe,
Kroenke, Herzog, & Gräfe, 2004; Williams et al., 2005).
Anxiety symptoms were assessed using the Beck Anxiety Inventory (BAI), a 21-item
self-report measure with good reliability and validity (Beck, Epstein, Brown & Steer, 1988; Beck
& Steer, 1993). The BAI was selected due to its wide use and validity as a screening tool for
elevated anxiety symptoms in community mental health settings (Eack, Singer, & Greeno, 2008).
On the BAI, patients rate how bothered they were by symptoms over the past two weeks on a
four-point scale ranging from “Not at all” (0) to “Severely- it bothered me a lot” (3). Total scores
range from 0 to 63, with scores from 16-25 indicating moderate anxiety symptoms and scores ≥
26 indicating severe anxiety symptoms.
Predictor. Treatment condition served as the predictor variable. EUC was coded as “0”
and brief CBT was coded as “1.”
Mediators. In the present study, data from the 4-month follow-up assessment was used
for mediator variables. T-tests were conducted to assess for baseline differences in mediator
variables; as mediator variables did not differ significantly by treatment group at baseline,
baseline measures of these mediators were not included in analyses.
The Illness Intrusiveness Rating Scale (IIRS; Devins, 2010) was used as a measure of
primary appraisal. The IIRS is a 13-item self-report measure with good psychometric properties
(Devins, 2010). Using a 7-point scale ranging from “not very much” (1) to “very much” (7), the
IIRS assesses the extent to which chronic illness intrudes upon meaningful life activities. For this
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study, patients were directed to think about how much their COPD, HF, and/or its treatment
interfere with daily life. In addition to a total score, there are three subscales: relationships and
personal development, intimacy, and instrumental. The total score was used in the present study.
The Self-Efficacy for Managing Chronic Diseases scale (Lorig, Sobel, Ritter, Laurent, &
Hobbs, 2001) was used as a measure of secondary appraisal. This is a 6-item self-report measure
that is well-validated and has good psychometric properties (Ritter & Lorig, 2014). On a 10point scale ranging from “not at all confident” (1) to “totally confident” (10), participants rate
their perceived ability to manage the symptoms associated with their chronic disease and prevent
these symptoms from impacting their functioning in various domains. The score for this scale is
the mean of the six items.
Coping style was assessed using the Brief COPE, a 28-item self-report measure with
good reliability and validity (Carver, 1997). On the Brief COPE, patients are presented with
statements about various coping strategies they may use when they experience stress and are
asked to rate what they usually do on a 4-point scale ranging from “I usually don’t do this at all”
(1) to “I usually do this a lot” (4). The 28 items form 14 subscales, each composed of two items.
Carver (1989) notes that composition of higher-order factors may vary due to characteristics of
different samples, and therefore recommends that researchers conduct their own analyses to
examine the relationships between subscales. Therefore, a principal components analysis was
conducted to reduce the number of components of the Brief COPE. This extraction method was
selected to maximize the amount of variance accounted for and to maintain consistency with
previous methodology using the Brief COPE in this sample. Parallel analysis indicated a two
component solution. Varimax rotation was used to prevent cross-loading of subscales, since
theory suggests that avoidant and active coping are non-orthogonal. Results yielded two
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components, interpreted to correspond with active coping and avoidant coping (see Table 2).
Internal consistency of the active coping and avoidant coping components was acceptable,
though the consistency of avoidant coping was lower (Cronbach’s α = .78 and .67, respectively).
Although the two components accounted for less than half of the variance in the Brief COPE, the
two components corresponded to a previous principal component analysis conducted with a
subsample of the current study sample (Hundt et al., 2013), and were consistent with the
literature more broadly (Holahan & Moos, 1985; Roth & Cohen, 1986).
Table 2
Two components of the Brief COPE
Active Coping

Avoidant Coping

Eigenvalue = 4.0

Eigenvalue = 2.1

Planning (.75)

Behavioral Disengagement (.74)

Positive Reframing (.75)

Denial (.74)

Emotional Support (.74)

Self-Blame (.74)

Active Coping (.73)

Venting (.68)

Instrumental Social Support (.73)

Self-Distraction (.29)

Acceptance (.55)

Planning (.22)

Religious Coping (.54)

Positive Reframing (.09)

Self-Distraction (.54)

Acceptance (-.15)

Venting (.26)

Instrumental Social Support (.11)

Humor (.22)

Religious Coping (-.11)
(continued)
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Active Coping

Avoidant Coping

Eigenvalue = 4.0

Eigenvalue = 2.1

Denial (.10)

Active Coping (.08)

Behavioral Disengagement (-.08)

Emotional Support (-.08)

Self-Blame (.03)

Substance Use (.01)

Substance Use (-.03)

Humor (.00)

Note. Results of a principal components analysis using varimax rotation. Together, the two components explained
43.30 percent of the variance in the Brief COPE. Factors were interpreted to represent active coping (accounting for
28.65% of the variance) and avoidant coping (accounting for 14.66% of the variance). Substance Use and Humor
did not load strongly on either factor and were excluded from analyses.

Statistical Analyses
All analyses were conducted in SPSS Version 24 using Hayes’s (Darlington & Hayes,
2016) PROCESS Macro, Version 2.16. Hypotheses were examined using multiple mediation
analyses, which involve “simultaneous mediation by multiple variables” (Preacher & Hayes,
2008, p. 880). In mediation analyses, the indirect effect is the product of the regression
coefficients between the predictor (in this case, treatment condition) and the outcome (i.e.,
depression or anxiety) through the mediator. According to Preacher and Hayes (2008), there are
two steps to testing a multiple mediation model: a) analysis of the combined effect of all
mediators in the model, or the total indirect effect, and b) analysis of the effects of each mediator
individually, or the specific indirect effects. In the present study, the specific indirect effect was
defined as the indirect effect of a particular mediator (aibi). The total indirect effect was defined
as the sum of the indirect effects of all mediators in the model ∑i(aibi), i = 1 to j mediators.
Two models were examined: 1) the relationship between treatment condition and
depression, as mediated by illness intrusiveness, self-efficacy, and coping, and 2) the relationship
between treatment condition and anxiety, as mediated by illness intrusiveness, self-efficacy, and
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coping. Participants with significant depression symptoms only or significant symptoms of both
depression and anxiety at baseline were included in analysis of the first model and participants
with significant anxiety symptoms only or significant symptoms of both depression and anxiety
at baseline were included in analysis of the second model. Therefore, there was considerable
overlap between the participants included in analyses of both models.
Bootstrapping, a nonparametric resampling procedure, was used to test the significance
of indirect effects. Bootstrap analyses draw randomly with replacement from the initial sample,
creating thousands of random samples of the same size as the initial sample. This distribution of
random samples is then used to repeatedly calculate the statistic of interest and generate a
confidence interval. Bootstrapping has several advantages: it does not assume multivariate
normality, provides greater statistical power, and allows for parsimonious analysis of multiple
mediators (Mallinckrodt, Abraham, Wei, & Russell, 2006; Preacher & Hayes, 2008).
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RESULTS
Sample Characteristics
Overall, the full sample (N = 302) was older in age (M = 65.53 years) and predominantly
male (94.4%). A majority of participants were white (67.9%), with African Americans
representing the largest racial minority in the sample (22.8%). Over half of participants (59.3%)
had completed more than 12 years of education and 61.3% were married. Regarding chronic
health conditions, 61.9% of participants had only COPD, 24.8% had only HF, and 13.2% had
both. Of those randomized, 24.5% (n = 74) had elevated symptoms of depression only (PHQ-9 ≥
10), 12.6% (n = 38) had elevated anxiety symptoms only (BAI ≥16), and 62.9% (n = 190) had
both. As assessed by the MINI, 180 (59.6%) participants met full diagnostic criteria for a
depression or anxiety disorder based on DSM-IV-TR criteria. For a description of the
sociodemographic and clinical characteristics of patients with significant anxiety and/or
depression symptoms at baseline in comparison to the full sample, see Table 3 (page 44).
Chi-square goodness-of-fit and t-tests indicated that sociodemographic and clinical
characteristics did not differ significantly between participants in the brief CBT and EUC
treatment conditions at baseline (Table 4 on page 46). For the clinical intervention group,
treatment completion was a priori defined as receiving at least 4 sessions of brief CBT. Chisquare goodness-of-fit and t-tests also revealed that treatment completers and non-completers did
not differ significantly in terms of sociodemographic or clinical characteristics including
depression, anxiety, and chronic illness severity.
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Table 3
Sociodemographic and Baseline Clinical Characteristics of Participants with Significant Depression and Anxiety
Symptoms
Significant
Significant Baseline Significant Baseline
Full Sample
Baseline Anxiety

Depression Only

Anxiety and

Only (n = 38)

(n = 74)

Depression (n = 190)

(N = 302)

N

%

N

%

N

%

N

%

Male

35

92.1

69

93.2

181

95.3

284

94.4

Female

3

7.9

5

6.8

9

4.7

17

5.6

<12 years

5

13.2

4

5.4

15

7.9

24

8.0

12 years

10

26.3

28

37.8

61

32.1

99

32.8

>12 years

23

60.5

42

56.8

114

67.9

179

59.3

White

25

65.8

54

73.0

126

66.3

205

67.9

African American

10

26.3

14

18.9

45

23.7

69

22.8

Hispanic

2

5.3

0

0.0

6

3.2

8

2.6

Other

1

2.6

6

8.1

13

6.8

20

6.6

COPD only

24

63.2

41

55.4

122

64.2

187

61.9

HF only

9

23.7

21

28.4

45

23.7

75

24.8

COPD & HF

5

13.2

12

16.2

23

12.1

40

13.2

Married

24

63.2

38

51.4

123

64.7

185

61.3

Divorced/Separated

9

23.7

22

29.7

46

24.2

77

25.5

Widowed

4

10.5

12

16.2

13

6.8

29

9.6

Never Married

1

2.6

2

2.7

8

4.2

11

3.6

Gender

Education

Race

Health Condition(s)

Marital Status

(continued)
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Significant

Significant Baseline

Significant Baseline

Full Sample

Baseline Anxiety

Depression Only

Anxiety and

(N = 302)

Only (n = 38)

(n = 74)

Depression (n = 190)

M

SD

M

SD

M

SD

M

SD

Age

67.92

9.20

66.74

9.01

64.55

8.19

65.53

8.60

MRC Grade

4.00

0.87

3.88

0.74

4.08

.71

4.02

0.74

NYHA Class

3.07

0.73

3.18

0.68

3.21

0.68

3.18

0.68

BAI

20.92

4.97

20.89

3.20

26.59

8.33

22.03

9.64

PHQ-9

7.03

1.79

12.93

2.91

16.19

18.30

14.24

4.83

Illness

47.63

12.52

52.45

15.61

59.85

15.27

56.50

15.68

Self-Efficacy

4.97

1.90

4.71

1.70

4.28

1.76

4.48

1.78

Avoidant Coping

9.32

3.29

10.59

3.17

11.85

4.16

11.22

3.92

Active Coping

20.40

4.84

18.83

4.36

21.12

4.51

20.46

4.60

Intrusiveness

Note. Demographic characteristics and baseline clinical characteristics are described in frequencies and percentages
or means and standard deviations, as appropriate, for patients with significant baseline anxiety symptoms only,
patients with significant baseline depression symptoms only, patients with significant baseline symptoms of both
depression and anxiety, and for the full sample. Significant baseline anxiety is defined as BAI ≥ 16 at baseline
assessment. Significant baseline depression is defined as PHQ-9 ≥ 10 at baseline assessment. n = frequency; % =
percentage; M = mean; SD = standard deviation; MRC = Medical Research Council Dyspnea Scale; NYHA = New
York Heart Association Functional Classification; BAI = Beck Anxiety Inventory; PHQ-9 = Patient Health
Questionnaire.

Multiple Mediation Analyses
Per Hayes’ (2013) recommendation for multiple mediation models, 10,000 bootstrap
samples were generated to produce parameter estimates for total and specific indirect effects. If
the 95% bias-corrected confidence interval around the parameter estimate did not contain zero,
this indicated that the indirect effect was statistically significant and demonstrated mediation
(Mallinckrodt et al., 2006; Preacher & Hayes, 2008). At baseline, there were no significant
differences in illness intrusiveness, self-efficacy, active coping, avoidant coping, anxiety, or
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depression between treatment groups; therefore, no covariates were included in multiple
mediation models.
Table 4
Comparison of baseline sociodemographic and clinical characteristics by treatment condition
Brief CBT (n = 180)
EUC (n = 122)
χ2
N

%

N

%

Male

168

93.3

116

95.1

Female

11

6.1

6

4.9

<12 years

11

6.1

13

10.7

12 years

62

34.4

37

30.3

>12 years

106

58.9

72

59.0

White

119

66.1

85

69.7

African American

42

23.3

27

22.1

Hispanic

3

1.7

5

4.1

Other

15

8.3

5

4.1

COPD only

111

61.7

75

61.5

HF only

44

24.4

31

25.4

COPD & HF

24

13.3

16

13.1

Married

115

63.9

69

56.6

Divorced/Separated

43

23.9

34

27.9

Widowed

14

7.8

15

12.3

Never Married

7

3.9

4

3.3

p

Gender

0.21

.65

3.32

.65

3.77

.29

0.03

.99

3.87

.42

Education

Race

Health Condition(s)

Marital Status

(continued)
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Brief CBT (n = 180)

EUC (n = 122)

T

p

M

SD

M

SD

Age

64.78

8.71

66.51

8.30

1.72

.09

MRC Grade

3.97

0.76

4.11

0.70

-0.16

.87

NYHA Class

3.19

0.70

3.17

0.67

1.39

.17

BAI

21.41

8.87

22.91

10.67

1.28

.20

PHQ-9

13.80

4.64

14.88

5.07

1.90

.06

Illness Intrusiveness

56.92

15.06

55.83

16.63

-0.59

.56

Self-Efficacy

4.64

1.74

4.22

1.81

-1.87

.06

Avoidant Coping

11.09

3.92

11.40

3.95

0.68

.50

Active Coping

20.21

4.45

20.82

4.82

1.13

.26

Note. χ2 and t-tests indicated no significant differences in baseline characteristics of participants randomized to brief
cognitive behavioral therapy (CBT) or enhanced usual care (EUC). Demographic and baseline clinical
characteristics are described in frequencies and percentages or means and standard deviations, as appropriate, for
both treatment groups. COPD = chronic obstructive pulmonary disease; HF = heart failure; MRC = Medical
Research Council Dyspnea Scale, NYHA = New York Heart Association Functional Classification, BAI = Beck
Anxiety Inventory, PHQ-9 = Patient Health Questionnaire.

Depression. Of the 264 participants with significant symptoms of depression (including
those with significant symptoms of depression only (n = 74) and those with significant
symptoms of both depression and anxiety (n = 190) at baseline, 67 were lost to follow-up (see
Figure 1), for a total of 197 participants included in the multiple mediation analysis. The total
effect was statistically significant (95% CI [-4.75, -1.71]), indicating that participants who
received brief CBT had less severe symptoms of depression at 4-month follow-up than those
who received EUC (c = -3.23).1 The total indirect effect of treatment condition through the four
mediators was significant (ab = -1.58, SE = .48; 95% CI [-2.62, -0.66]). Therefore, the specific

1

A multiple mediation analysis was also conducted with a dichotomous treatment response variable as the outcome.
Patients with a 50% reduction in PHQ-9 and/or PHQ-9 < 10 at 4-month follow-up were considered treatment
responders and coded as ‘1’ while non-responders were coded as ‘0.’ Results were consistent with the primary
analyses, with self-efficacy and avoidant coping significantly mediating the relationship between treatment
condition and treatment response for depression (see Appendix B for a summary of results).
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indirect effects of treatment condition on depression through each of the four mediators was
examined. For 4-month follow-up means of depression, illness intrusiveness, self-efficacy, active
coping, and avoidant coping for patients with elevated symptoms of depression at baseline, see
Table 5.
Table 5
Means and standard deviations of outcomes and mediators at 4-month follow-up for patients with significant
baseline depression
Brief CBT (n = 180)
EUC (n = 122)
Full Sample (n = 197)
M

SD

M

SD

M

SD

BAI

17.77

8.92

23.39

11.39

20.13

10.53

PHQ-9

10.65

5.00

13.93

5.82

12.14

5.69

Illness Intrusiveness

52.64

17.13

56.76

15.97

54.62

16.86

Self-Efficacy

5.14

1.82

4.63

1.84

4.92

1.83

Avoidant Coping

13.07

3.67

15.10

5.02

13.92

4.45

Active Coping

42.96

9.95

41.07

9.09

42.10

9.59

Note. Means and standard deviations of outcomes and mediators at 4-months follow-up were calculated for patients
with significant baseline depression symptoms only. Descriptive statistics are reported for patients randomized to
brief CBT, to EUC, and for the full sample. Significant baseline depression is defined as PHQ-9 ≥ 10 at baseline
assessment. M = mean; SD = standard deviation; BAI = Beck Anxiety Inventory; PHQ-9 = Patient Health
Questionnaire.

The specific indirect effects of treatment condition through illness intrusiveness and
active coping were not statistically significant, as demonstrated by confidence intervals that
contained zero. In contrast, the specific indirect effects of treatment condition through selfefficacy and avoidant coping were significant (95% CIs [-0.93, -0.05] and [-1.32, -0.24],
respectively). Participants who received brief CBT had higher self-efficacy at 4-month follow-up
(a2 = 0.51), which in turn was associated with less severe depressive symptoms (b2 = -0.80).
Additionally, participants who received brief CBT engaged in less avoidant coping at 4-month
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follow-up (a4 = -1.98), and participants who engaged in less avoidant coping had less severe
depressive symptoms (b4 = 0.34).
The direct effect was significant (c’ = -1.65, 95% CI [-2.95, -0.35]), indicating that the
mediators in the model did not fully account for improvements in depression associated with
brief CBT. Table 6 contains the parameter estimates for the total effect, direct effect, total
indirect effect, and specific indirect effects of the relationship between treatment condition and
depression as mediated by illness intrusiveness, self-efficacy, active coping, and avoidant
coping. For a visual representation of the multiple mediation model for depression, see Figure 2.
Table 6
Total, direct, and indirect effects of treatment condition on symptoms of depression
95% BC CI
Effect

SE

Lower

Upper

Total Effect

-3.23

.77

-4.75

-1.71

Direct Effect

-1.65

.66

-2.95

-0.35

Total Indirect Effect

-1.58

.44

-2.62

-0.66

Illness Intrusiveness

-0.36

.23

-0.94

0.01

Self-Efficacy

-0.41

.22

-0.93

-0.05

Avoidant Coping

-0.68

.27

-1.32

-0.24

Active Coping

-0.14

.13

-0.52

0.02

Specific Indirect Effects

Note. The total effect of treatment condition on symptoms of depression is equal to the sum of the direct effect of
treatment condition and the total indirect effect of treatment condition. The total indirect effect of treatment
condition on symptoms of depression is equal to the sum of the specific indirect effects of treatment condition
through illness intrusiveness, self-efficacy, active coping, and avoidant coping. All reported effects are
unstandardized, as recommended by Hayes (2013). BC CI = bias corrected confidenc e interval; SE = standard error.
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Figure 2. Multiple Mediation Model for Depression with Unstandardized Path Coefficients

Anxiety. Of the 228 participants with significant symptoms of anxiety (including those
with significant symptoms of anxiety only (n = 38) and those with significant symptoms of both
depression and anxiety (n = 190) at baseline, 55 were lost to follow-up (see Figure 1), for a total
of 173 participants included in the multiple mediation analysis. The total effect was significant
(95% CI [-9.68, -4.05]). This indicated that participants who received brief CBT had less severe
anxiety symptoms at 4-month follow-up than those who received EUC (c = -6.87).2 The total
indirect effect of treatment condition through the four mediators was significant (ab = -2.73;
95% CI [-4.75, -1.06]). Therefore, the specific indirect effects of treatment condition on anxiety
symptoms through each of the mediators was examined. For 4-month follow-up means of

2

A multiple mediation analysis was also conducted with a dichotomous treatment response variable as the outcome.
Patients with a 50% reduction in BAI and/or BAI < 16 at 4-month follow-up were considered treatment responders
and coded as ‘1’ while non-responders were coded as ‘0.’ Results were mostly consistent with the primary analyses,
with self-efficacy and avoidant coping significantly mediating the relationship between treatment condition and
treatment response for anxiety (see Appendix C for a summary of results). However, illness intrusiveness did not
significantly mediate the relationship between treatment condition and treatment response for anxiety.
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depression, illness intrusiveness, self-efficacy, active coping, and avoidant coping for patients
with elevated symptoms of anxiety at baseline, see Table 7.
Table 7
Means and standard deviations of outcomes and mediators at 4-month follow-up for patients with significant
baseline depression
Brief CBT (n = 180)
EUC (n = 122)
Full Sample (n = 174)
M

SD

M

SD

M

SD

BAI

19.14

8.36

26.03

10.41

22.03

9.90

PHQ-9

10.14

5.02

14.29

5.75

12.01

5.78

Illness Intrusiveness

53.20

16.74

57.56

14.52

55.14

15.93

Self-Efficacy

5.25

1.79

4.62

1.69

4.97

1.77

Avoidant Coping

12.87

3.87

15.00

5.06

13.74

4.54

Active Coping

42.97

9.78

42.49

8.82

42.77

9.36

Note. Means and standard deviations of outcomes and mediators at 4-months follow-up were calculated for patients
with significant baseline anxiety symptoms only. Descriptive statistics are reported for patients randomized to brief
CBT, to EUC, and for the full sample. Significant baseline anxiety is defined as BAI ≥ 16 at baseline assessment. M
= mean; SD = standard deviation; BAI = Beck Anxiety Inventory; PHQ-9 = Patient Health Questionnaire.

The specific indirect effect of treatment condition through active coping was not
significant, as demonstrated by a confidence interval that contained zero. In contrast, the specific
indirect effects of treatment condition through illness intrusiveness, self-efficacy, and avoidant
coping were significant (95% CIs [-1.39, -0.01], [-1.65, -0.17], and [-3.11, -0.49], respectively).
Participants who received brief CBT perceived their chronic illness to be less intrusive at 4 month follow-up (a1 = -4.29); illness intrusiveness was positively associated with anxiety
symptoms (b1 = 0.12), so the overall indirect effect through illness intrusiveness was negative.
Brief CBT was also associated with higher self-efficacy at 4-month follow-up (a2 = 0.63), and
higher self-efficacy was related to less anxiety (b2 = -1.13). Additionally, participants who
received brief CBT engaged in less avoidant coping at 4-month follow-up (a3 = -2.08), which
was related to less severe anxiety symptoms (b3 = 0.74).
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The direct effect was significant (c’ = -4.13, SE = 1.24; 95% CI [-6.58, -1.69]), indicating
that the mediators in the model did not fully account for improvements in anxiety symptoms
associated with brief CBT. Table 8 contains the parameter estimates for the total effect, direct
effect, total indirect effect, and specific indirect effects of the relationship betw een treatment
condition and anxiety as mediated by illness intrusiveness, self-efficacy, active coping, and
avoidant coping. For a visual representation of the multiple mediation model for anxiety, see
Figure 3.
Table 8
Total, direct, and indirect effects of treatment condition on symptoms of anxiety
95% BC CI
Effect

SE

Lower

Upper

Total Effect

-6.87

1.43

-9.68

-4.05

Direct Effect

-4.13

1.24

-6.58

-1.69

Total Indirect Effect

-2.73

.93

-4.75

-1.06

Illness Intrusiveness

-0.50

.34

-1.39

-0.01

Self-Efficacy

-0.72

.36

-1.65

-0.17

Avoidant Coping

-1.54

.66

-3.11

-0.49

Active Coping

0.02

.12

-0.13

0.44

Specific Indirect Effects

Note. The total effect of treatment condition on symptoms of anxiety is equal to the sum of the direct effect of
treatment condition and the total indirect effect of treatment condition. The total indirect effect of treatment
condition on symptoms of anxiety is equal to the sum of the specific indirect effects of treatment conditio n through
illness intrusiveness, self-efficacy, active coping, and avoidant coping. All reported effects are unstandardized, as
recommended by Hayes (2013). BC CI = bias corrected confidence interval; SE = standard error.
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Figure 3. Multiple Mediation Model for Anxiety with Unstandardized Path Coefficients
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DISCUSSION
The purpose of this study was to use the transactional model of stress and coping as a
framework to examine potential mechanisms of action of brief CBT for veterans with physical
and psychological comorbidities. Participants who received brief CBT tended to experience
lower symptoms of depression and anxiety at 4-month follow-up than participants randomized to
EUC. Further, supplemental analyses revealed that those who received brief CBT were more
likely to be considered treatment responders (i.e., PHQ-9 < 10, BAI < 16, or 50% or greater
reduction in PHQ-9 or BAI scores) at 4-month follow-up. These results suggest that brief CBT
leads to clinically significant change in symptoms of depression and anxiety.
Consistent with the hypotheses, the relationships between treatment condition and
symptoms of depression and anxiety were mediated by appraisals and coping. In particular, brief
CBT was associated with higher appraisals of self-efficacy and less avoidant coping, which were
related to clinically significant improvements in depression and anxiety. Brief CBT was also
associated with lower anxiety symptoms through lower appraisals of illness intrusiveness.
However, illness intrusiveness did not predict clinically significant changes in anxiety
symptoms. These results suggest that, for patients with elevated symptoms of anxiety and/or
depression and comorbid medical conditions, brief CBT may work by increasing self-efficacy
and reducing use of avoidant coping strategies. Additionally, changing perceptions about the
intrusiveness of chronic illness symptoms appears to be another pathway by which brief CBT
reduces anxiety, but not depression. However, these reductions may not be clinically meaningful.
Although preliminary, these results reflect the promise of the transactional model of stress and
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coping as a framework for understanding mechanisms of brief CBT for patients with medical and
mental health comorbidities.
Primary Appraisals
In accordance with the transactional model of stress and coping (Lazarus & Folkman,
1984), previous literature suggests that appraisal of chronic illness as more intrusive or as posing
a loss, a potential harm, or a threat is associated with poorer psychological adjustment (Bigatti et
al., 2012). Further, prior psychological interventions among medically ill populations led to
reductions in perceived illness intrusiveness (Edworthy et al., 2003). In combination, these
relationships suggest that clinical improvements may result from changes in primary appraisal of
chronic illness symptoms.
In the present study, brief CBT was associated with lower perceived intrusiveness of
chronic illness symptoms among patients with elevated symptoms of depression and anxiety.
Interestingly, this translated to lower anxiety symptoms, but not depressive symptoms. Lower
illness intrusiveness was not associated with clinically meaningful changes in anxiety symptoms,
however. These results suggest that, while brief CBT does improve anxiety symptoms by
reducing perceptions of illness intrusiveness, these changes in anxiety may not be appreciable. It
is possible that illness intrusiveness may not have meaningfully impacted anxiety symptoms
because it was not sufficiently emphasized in the current brief CBT protocol.
It is also important to consider how the specific type of appraisals associated with typical
maladaptive cognitive patterns in depression and anxiety may help to explain the association of
illness intrusiveness with lower symptoms of anxiety but not depression. There is a strong link
between threat appraisal and anxiety, such that individuals with anxiety disorders tend to be
biased to perceive stimuli as more threatening (e.g., with the potential for causing future harm)
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compared to those without anxiety disorders (Britton, Lissek, Grillon, Norcross, & Pine, 2011).
Threat re-appraisal is also one of the most well-studied mediators of CBT and anxiety (Smits et
al., 2012). Although the constructs of illness intrusiveness and threat re-appraisal are distinct,
perceptions of the degree to which chronic illness symptoms interfere with functioning are
conceptually related to appraisals of threat to health, employment, relationships, and other valued
roles and abilities. These ties between threat appraisal, illness intrusiveness, and anxiety,
combined with the results of this study, suggest that brief CBT may lead to re-appraisal of
chronic illness symptoms as less intrusive and threatening, which is then associated with fewer
symptoms of anxiety.
Another construct that may further elucidate the relationship between illness
intrusiveness and anxiety symptoms is anxiety sensitivity. Those high in anxiety sensitivity are
more aware of, attuned to, and distressed by both cognitive and physical symptoms of anxiety
(Taylor, 2014). Therefore, brief CBT may help attenuate anxiety sensitivity, reducing both
perceptions of illness intrusiveness and anxiety symptoms.
In contrast to anxious cognitions about threat and future harm, depressive ruminations are
more closely related to perceptions of loss of past identity and functional ability among those
with chronic illness (Chan, Brooks, Erlich, Chow, & Suranyi, 2009). While this may partially
explain the lack of association between illness intrusiveness and depression, other studies
indicate that CBT decreases depressive symptoms through changes in ruminative cognitions
(Watkins et al., 2011). Therefore, it is possible that brief CBT impacts depression through
primary appraisals of chronic illness, but that the construct of illness intrusiveness does not
capture the type of appraisal (e.g., loss) characteristic of depression. Consequently, appraisal of
loss warrants study as a mediator of therapeutic change in depressive symptoms.
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Secondary Appraisals
The transactional model of stress and coping holds that secondary appraisals about one’s
ability to employ strategies to effectively manage chronic illness should have an impact on
psychological adjustment. In addition to demonstrating a strong link between self-efficacy and
mental health (Joekes et al., 2007; McCathie et al., 2002), previous studies have suggested that
self-efficacy may be increased through psychological intervention in patients with chronic
medical conditions (Kaplan et al., 1984; O’Leary et al., 1988). Therefore, the present finding that
brief CBT was associated with clinically significantly lower depression and anxiety symptoms
through greater self-efficacy is consistent with both theory and past research. Tentatively it
appears that enhancing self-efficacy may be one of the mechanisms by which brief CBT leads to
improvements in depression and anxiety symptoms among patients with COPD and HF.
Coping
The strategies employed to cope with a stressor are related to psychological adjustment,
per the transactional model of stress and coping (Lazarus & Folkman, 1984). For individuals
with medical illness, avoidant coping strategies, which tend to ignore or discount problems, have
been consistently linked to poorer psychological health (Duangdao & Roesch, 2008; Jensen et
al., 1991; Moskowitz et al., 2009). CBT helps to reduce avoidance behavior, and this change is
associated with improved mood and functioning (Deale, Chalder & Wessely, 1998). In keeping
with prior research, avoidant coping was a significant mediator of the relationship between brief
CBT and clinically meaningful reductions in depression and anxiety symptoms in the present
study. This result lends credence to the hypothesis that reducing avoidant coping is one of th e
mechanisms by which brief CBT improves psychological health.
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In addition to avoidant coping strategies, the present study examined use of active coping
strategies, which include strategies such as positive reframing, planning, and acceptance. Among
individuals with cancer, CBT is linked to greater active coping (Moorey et al., 2003). Consistent
with this finding, brief CBT was associated with increased use of active coping strategies.
Greater active coping did not correspond to lower depression or anxiety, though. This finding is
inconsistent with prior research that has found active coping to significantly predict
psychological adjustment among patients with diabetes, HIV, and chronic pain (Duangdao &
Roesch, 2008; Jensen et al., 1991; Moskowitz et al., 2009). It is possible that, in contrast to other
chronic medical conditions, active coping is not an important pathway through which brief CBT
improves psychological adjustment for patients with COPD and HF. However, there are several
lines of research that help elucidate the present findings.
First, research on positive affect and coping may provide insight into the role of active
coping in psychological functioning. Folkman and Moskowitz (2000) have argued that positive
affect is an understudied and important aspect of coping with chronic illness. Positive affect still
occurs within the context of comorbid physical and psychological disorders and may serve an
important role in alleviating distress (Folkman, 1997). Indeed, there is evidence that positive
affect helps to buffer the harmful physiological effects of stress by regulating neural, endocrine,
and immune responses, as well as cardiovascular functioning (Epel, McEwen & Ickovics, 1998;
Fredrickson & Levenson, 1998). Specific active coping strategies such as positive reappraisal
and problem-focused coping have been linked to increased positive affect (Moskowitz, Folkman,
Collette, & Vittinghoff, 1996). Therefore, it may be that active coping is more closely related to
increased positive affect than decreased negative affect among patients with COPD and/or HF.
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The goodness of fit hypothesis also provides important suggestions about the relationship
between active coping and psychological symptoms among those with chronic medical
conditions. According to this hypothesis (Folkman & Lazarus, 1980), appraisal of a situation as
controllable should be linked to problem-focused coping strategies (e.g., planning), while
appraisal of a situation as uncontrollable should be linked to emotion-focused coping strategies
(e.g., positive reframing). Good fit between appraisal of controllability and the type of coping
strategies used should theoretically be associated with better psychological functioning. In a
study of individuals with physical health conditions (Vitaliano, DeWolfe, Maiuro, Russo &
Katon, 1990), problem-focused coping was only associated with fewer depressive symptoms
when health condition was perceived as controllable. Similarly, emotion-focused coping was
associated with more severe depression when health condition was perceived as controllable.
Goodness of fit between appraised controllability and type of coping strategy used may also play
an important role in the psychological adjustment of patients with COPD and HF. This
relationship is difficult to parse in the present study, though, because perceived controllability
was not measured and the active coping factor consisted of both emotion-focused and problemfocused coping strategies.
Finally, there is precedent for a significant relationship between functioning and
avoidant, not active, coping in individuals with medical illness. In a study of men with cancer
(Hoyt, Thomas, Epstein, & Dirksen, 2009), avoidant coping was a significant predictor of poor
sleep quality, while active coping was not significantly related to sleep. Hoyt and colleagues
(2009) found that depressive symptoms partially mediated the relationship between avoidant
coping and sleep problems. In their explanation of this finding, the authors noted significant
conceptual overlap between avoidant coping and depressive symptoms. Avoidance is also one of
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the core features of anxiety (Mkrtchian, Aylward, Dayan, Rosier, & Robinson, 2017). The strong
link between avoidant coping and psychological symptoms may contribute to the nonsignificant
relationship between active coping and psychological adjustment.
Limitations
Measurement, intervention, and sample characteristics of the study limit the conclusions
which may be drawn from the results. Due to concurrent measurement of mediators and outcome
variables, causal relationships between components of the transactional model and depression
and/or anxiety cannot be established. It is possible that brief CBT leads to simultaneous changes
in these variables or that reciprocal relationships exist. Additionally, there are some limitations to
the outcome measures used in the present study. The PHQ-9 and BAI both have several items
that may correspond to both physical and mental health symptoms. For older adults with chronic
medical conditions, scores may be inflated and may not change with intervention because
physical health symptoms have not changed. Therefore, these measures may not capture the full
impact of the intervention on mental health symptoms.
Regarding the intervention, it is difficult to know which components contributed to
changes in mediators and outcomes. Brief CBT was highly customizable, allowing providers and
participants to collaboratively select modules that best fit the participant’s unique concerns. This
flexible protocol mirrors real-world delivery of brief psychological interventions in primary care
and provides a high degree of external validity; however, it limits the links that may be drawn
between treatment elements and potential mechanisms of action, since not every participant
received every treatment module. Additionally, the treatment dose received varied among
participants, including those who completed brief CBT. Some participants who completed
treatment received only 4 sessions, while others received 5 or 6. The length of sessions also
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ranged from 30-45 minutes, which could further contribute to differences in depth of exposure to
intervention elements. These differences make it difficult to pinpoint the minimum dose of brief
CBT necessary to elicit change in potential mechanisms of action and outcomes. It is also
important to note that the intervention was delivered by providers from different training
backgrounds, ranging from physician assistants to psychologists, with varying levels of
experience with CBT. As therapist experience has a small but significant effect on treatment
outcomes (Di Giulio, 2007), this may have contributed to changes in depression and anxiety.
Finally, the characteristics of the study sample should be considered, as results may not
generalize to other populations. Participants in the present sample were veterans, primarily
Caucasian, mostly men, and generally older in age. The role of appraisals and coping may differ
for other populations. For example, a study examining women with breast cancer suggest s that
appraisals of illness intrusiveness may play a more important role in the psychological
adjustment of younger adults (Lebel, Beattie, Arès, & Bielajew, 2013).
Treatment Implications
Despite these limitations, this study provides initial evidence that brief CBT effectively
targets both cognitive and behavioral processes that are related to depression and anxiety in the
context of medical illness. Based on the results of this study, enhancing self-efficacy to manage
chronic illness and decreasing avoidant coping should be goals of intervention for those with
physical and psychological comorbidities. It may also be important to target perceptions of
illness intrusiveness for individuals with anxiety, but further evidence is needed to determine if
this will result in clinically meaningful change. The value of active coping is also less
immediately apparent, though it is possible that increasing active coping may lead to more
positive affect.
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Though not the focus of primary analyses, it is noteworthy that brief CBT had high rates
of treatment engagement and completion. These high rates of engagement and completion are
particularly noteworthy, given the typically low engagement rates for men and high dropout rates
for individuals with physical health conditions (Bertakis, Azari, Helms, Callahan, & Robbins,
2000; Freedland et al., 2009, 2015; Kunik et al., 2008). This finding provides further evidence
that delivery of psychological interventions in the primary care setting reduces stigma and
barriers to accessing care. The collaborative and customizable approach of brief CBT may also
contribute to treatment engagement and retention. Finally, incorporation of physical health selfmanagement skills appears to be particularly critical for patients with medical and mental health
comorbidities (Brandt et al., in preparation).
Future directions
This study represents an important first step in establishing a connection between brief
CBT, the transactional model of stress and coping, and psychological adjustment among patients
with chronic medical conditions. Ideally, future studies should take repeated measurements of
both proposed mediators and outcomes at timepoints across the study, to establish the
directionality of relationships (Kazdin, 2007). Confirmatory evidence of changes in appraisals
and coping occurring before changes in depression and anxiety would strongly support the
argument that these mediators are mechanisms of action of brief CBT. Establishing specificity of
these mediators through comparison of brief CBT to other interventions such as IPT would
provide further reinforcement that components of the transactional model are mechanisms of
action (Kazdin, 2007). Replicating the study in samples with other chronic medical conditions
would also increase confidence in the role of appraisals and coping as mechanisms of action of
brief CBT (Kazdin, 2007). To provide greater depth of understanding of the transactional model
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of stress and coping as a model for therapeutic change, the role of specific coping strategi es
should be examined in further depth, as should the fit between appraisals of controllability and
coping strategies. Potential moderators such as gender and age should also be investigated.
The effect of brief CBT on depression and anxiety was only partially mediated by
components of the transactional model of stress and coping. This indicates that the effect of brief
CBT on depression and anxiety was not fully explained by this model, as operationalized in the
present study. Additional measures of primary appraisal and secondary appraisal should be
included in future investigations of the transactional model. For example, a measure of threat,
harm-loss, or challenge orientation may provide additional information about primary appraisals
of chronic illness. Future studies may also expand beyond the transactional model to include
other known mediators of CBT, such as dysfunctional attitudes and threat re-appraisal. Behavior
changes not captured by measures of coping, such as medication adherence, should be examined
as mediators as well. Understanding the relative contribution of these variables and components
of the transactional model could provide suggestions about which skills and aspects of treatment
to emphasize. These theories may then be tested using component studies.
Finally, future research on brief CBT for patients with comorbid medical and mental
health conditions should examine positive affect, quality of life, and physical functioning as
outcomes. For individuals with physical and psychological comorbidities, the movement of
mental health services into primary care helps to facilitate a more holistic, integrated approach to
care. Another aspect of the movement toward holistic care advocates for an emphasis on
increasing quality of life and positive affect, rather than a sole focus on symptom reduction
(Asadi-Lari, Tamburini, & Gray, 2004). The transactional model of stress and coping may also
serve as a framework for understanding therapeutic changes in these variables.
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Conclusions
As the effectiveness of CBT has been well-established, research has increasingly focused
on understanding the processes by which CBT reduces psychological symptoms. Another area of
emphasis is the adaptation of CBT to new settings and populations. The present study inte grates
these lines of research and is one of the first to examine potential mechanisms of action of brief
CBT for patients with physical and psychological comorbidities. It appears that brief CBT may
lead to improvements in depression and anxiety by increasing self-efficacy to manage chronic
illness symptoms and by decreasing use of avoidant coping strategies. Furthermore, brief CBT
may lead to improvements in anxiety by decreasing perceived intrusiveness of chronic illness
symptoms. These results serve as preliminary evidence for the role of illness intrusiveness, selfefficacy, and avoidant coping as mechanisms of action of brief CBT. These findings also
illustrate the utility of the transactional model of stress and coping as a framework for
understanding how brief CBT works for patients with physical and psychological comorbidities.
The present study contributes to a small but growing body of literature considering
mediators of psychological interventions for patients with comorbid medical and mental health
conditions. This investigation is exceptional in its examination of all components of the
transactional model (e.g., primary appraisals, secondary appraisals, and coping strategies) as
parallel mediators. It is also novel in its focus on a psychological intervention delivered in the
primary care setting. This line of research is timely, given the need for increased access to
quality mental health care, and given the movement toward primary care mental health
integration.
In summary, brief CBT appears to be an effective intervention that increases access to
care for patients with comorbid medical and mental health conditions. To better understand how
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this intervention works and to discover potential methods of enhancing its effectiveness, future
research should continue to investigate mechanisms of action of brief CBT for patients with
physical and psychological comorbidities, using the transactional model of stress and coping as a
framework.
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APPENDIX A:
IRB APPROVAL LETTER
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APPENDIX B:
DEPRESSION TREATMENT RESPONSE MULTIPLE MEDIATION RESULTS
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Direct and indirect effects of treatment condition on treatment response for depression
95% BC CI
Effect

SE

Lower

Upper

Direct Effect

.36

.36

-0.34

1.06

Total Indirect Effect

.68

.26

0.23

1.22

Illness Intrusiveness

.14

.10

-0.01

0.42

Self-Efficacy

.17

.11

0.01

0.45

Avoidant Coping

.32

.16

0.09

0.71

Active Coping

.05

.06

-0.02

0.24

Specific Indirect Effects

Note. The total indirect effect of treatment condition on depression treatment response is equal to the sum of the
specific indirect effects of treatment condition through illness intrusiveness, self-efficacy, active coping, and
avoidant coping. All reported effects are unstandardized, as recommended by Hayes (2013). BC CI = bias corrected
confidence interval; SE = standard error.
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APPENDIX C:
ANXIETY TREATMENT RESPONSE MULTIPLE MEDIATION RESULTS
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Direct and indirect effects of treatment condition on treatment response for anxiety
95% BC CI
Effect

SE

Lower

Upper

Direct Effect

.62

.41

-0.19

1.43

Total Indirect Effect

.56

.25

0.16

1.14

Illness Intrusiveness

.10

.09

-0.01

0.35

Self-Efficacy

.16

.11

0.01

0.46

Avoidant Coping

.31

.18

0.06

0.78

Active Coping

-.01

.04

-0.16

0.04

Specific Indirect Effects

Note. The total indirect effect of treatment condition on anxiety treatment response is equal to the sum of the
specific indirect effects of treatment condition through illness intrusiveness, self-efficacy, active coping, and
avoidant coping. All reported effects are unstandardized, as recommended by Hayes (2013). BC CI = bias corrected
confidence interval; SE = standard error.
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APPENDIX D:
MEDICAL RESEARCH COUNCIL DYSPNEA SCALE
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MRC Dyspnea Scale
Grade

Degree of breathlessness related to activity

1

Not troubled by breathless except on strenuous exercise

2

Short of breath when hurrying on a level or when walking up
a slight hill

3

Walks slower than most people on the level, stops after a
mile or so, or stops after 15 minutes walking at own pace

4

Stops for breath after walking 100 yards, or after a few
minutes on level ground

5

Too breathless to leave the house, or breathless when
dressing/undressing

Adapted from Fletcher CM. The clinical diagnosis of pulmonary emphysema—an
experimental study. Proc R Soc Med 1952;45:577–584.

73

APPENDIX E:
NEW YORK HEART ASSOCIATION CLASSIFICATION
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APPENDIX F:
ILLNESS INTRUSIVENESS RATING SCALE
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APPENDIX G:
SELF-EFFICACY FOR MANAGING CHRONIC DISEASES SCALE
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APPENDIX H:
BRIEF COPE
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Brief COPE
These items deal with ways you've been coping with the stress in your life since you found out you were going to
have to have this operation. There are many ways to try to deal with problems. These items ask what you've been
doing to cope with this one. Obviously, different people deal with things in different ways, but I'm interested in how
you've tried to deal with it. Each item says something about a particular way of coping. I want to know to what
extent you've been doing what the item says. How much or how frequently. Don't answer on the basis of whether it
seems to be working or not—just whether or not you're doing it. Use these response choices. Try to rate each item
separately in your mind from the others. Make your answers as true FOR YOU as you can.
1 = I haven't been doing this at all
2 = I've been doing this a little bit
3 = I've been doing this a medium amount
4 = I've been doing this a lot
1. I've been turning to work or other activities to take my mind off things.
2. I've been concentrating my efforts on doing something about the situation I'm in.
3. I've been saying to myself "this isn't real.".
4. I've been using alcohol or other drugs to make myself feel better.
5. I've been getting emotional support from others.
6. I've been giving up trying to deal with it.
7. I've been taking action to try to make the situation better.
8. I've been refusing to believe that it has happened.
9. I've been saying things to let my unpleasant feelings escape.
10. I’ve been getting help and advice from other people.
11. I've been using alcohol or other drugs to help me get through it.
12. I've been trying to see it in a different light, to make it seem more positive.
13. I’ve been criticizing myself.
14. I've been trying to come up with a strategy about what to do.
15. I've been getting comfort and understanding from someone.
16. I've been giving up the attempt to cope.
17. I've been looking for something good in what is happening.
18. I've been making jokes about it.
19. I've been doing something to think about it less, such as going to movies,
watching TV, reading, daydreaming, sleeping, or shopping.
20. I've been accepting the reality of the fact that it has happened.
21. I've been expressing my negative feelings.
22. I've been trying to find comfort in my religion or spiritual beliefs.
23. I’ve been trying to get advice or help from other people about what to do.
24. I've been learning to live with it.
25. I've been thinking hard about what steps to take.
26. I’ve been blaming myself for things that happened.
27. I've been praying or meditating.
28. I've been making fun of the situation.
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Scales are computed as follows (with no reversals of coding):
Self-distraction, items 1 and 19
Active coping, items 2 and 7
Denial, items 3 and 8
Substance use, items 4 and 11
Use of emotional support, items 5 and 15
Use of instrumental support, items 10 and 23
Behavioral disengagement, items 6 and 16
Venting, items 9 and 21
Positive reframing, items 12 and 17
Planning, items 14 and 25
Humor, items 18 and 28
Acceptance, items 20 and 24
Religion, items 22 and 27
Self-blame, items 13 and 26
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